cephalosporin c has been researched along with Community Acquired Infection in 353 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 68 (19.26) | 18.2507 |
2000's | 114 (32.29) | 29.6817 |
2010's | 151 (42.78) | 24.3611 |
2020's | 20 (5.67) | 2.80 |
Authors | Studies |
---|---|
Bosheva, M; Cossey, V; Gardovska, D; Hamed, K; Hornik, CD; Kwinta, P; Litherland, K; Liubsys, A; Münch, HG; Polak, M; Rubino, CM; Ruehle, C; Schröpf, S; Smits, A; Snariene, R; Tomasik, T | 1 |
Soriano, A | 1 |
Chodick, G; Henig, O; Neuberger, A; Reiner-Benaim, A | 1 |
Brateanu, A; Imrey, PB; Le, P; Navaneethan, SD; Pallotta, AM; Patel, P; Rastogi, R; Rothberg, MB; Yu, PC | 1 |
Cilloniz, C; Gabarrus, A; Garcia-Vidal, C; Mendez, R; Menéndez, R; Peroni, H; Rico, V; Soriano, A; Torres, A | 1 |
Dryden, M; Kantecki, M; Leister-Tebbe, H; Stone, GG; Wilcox, M; Yan, JL | 1 |
Abate, G; Frisby, J; Wang, G | 1 |
Deshpande, A; Haessler, S; Imrey, PB; Lindenauer, PK; Patel, P; Rothberg, MB; Yu, PC; Zilberberg, MD | 1 |
González-Jiménez, P; Latorre, A; Méndez, R | 1 |
Cilloniz, C; Pericàs, JM; Rojas, J | 1 |
Ahmed, D; Amin, MB; Asaduzzaman, M; Hossain, MI; Islam, MA; Islam, MR; Khan, R; Rahman, M; Riley, LW | 1 |
Alonso Álvarez, A; Llinares Modéjar, P; Míguez Rey, E; Ramos Merino, L; Sánchez Vidal, E; Serrano Areba, J; Sousa Regueiro, D | 1 |
Hammond, J; Kantecki, M; Stone, GG; Welte, T | 1 |
Bae, IG; Stone, GG | 1 |
Abe, Y; Fukuma, A; Hirade, T; Horie, A; Ito, T; Katou, F; Koike, D; Nariai, A; Saito, Y; Wakuri, M | 1 |
Chao, CM; Lai, CC; Lin, WT | 1 |
Amaro, R; Bassetti, M; Cilloniz, C; Giacobbe, DR; Graziano, E; Russo, A; Soriano, A; Torres, A; Vena, A | 1 |
Ito, M; Kimura, T; Onozawa, S | 1 |
Baltazar, ICL; Bonelli, RR; Caldera, S; de Araújo Longo, LG; de Sousa, VS; de Souza da-Silva, AP; Moreira, BM; Riley, LW; Santoro-Lopes, G | 1 |
Bernasconi, OJ; Campos-Madueno, EI; Endimiani, A; Luzzaro, F; Principe, L; Viaggi, V | 1 |
Basso, B; Crapis, M; Della Siega, P; Garlatti, E; Pontoni, E; Rosa, R; Tonizzo, M; Venturini, S | 1 |
Engelhardt, M; Gao, L; Hamed, K; Huang, H; Saulay, M | 1 |
Cammarata, AP; Hamed, K; Litherland, K; Polak, M; Rubino, CM; Schröpf, S; Smits, A | 1 |
Hong, MY; Hsieh, CC; Hung, YP; Ko, WC; Lee, CC; Lee, CH | 1 |
Corey, A; So, TY | 1 |
Castanheira, M; Flamm, RK; Jones, RN; Mendes, RE; Pfaller, MA; Sader, HS | 1 |
Eckburg, PB; File, TM; Friedland, HD; Llorens, L; Talbot, GH | 1 |
Bollinger, M; Britt, RS; Evoy, KE; Frei, CR; Jones, X; Lee, GC; Reveles, KR; Sorensen, KM | 1 |
Bus, K; Karpiuk, I; Kiljan, M; Michalska, K; Tyski, S | 1 |
Barberán, J; Sánchez Artola, B | 1 |
Badal, R; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S | 1 |
Chiodini, P; Fiore, M; Gentile, I; Gustot, T; Leone, S; Maraolo, AE; Pace, MC; Simeon, V; Taccone, FS | 1 |
Cardozo, C; Cilloniz, C; De la Calle, C; Del Rio, A; García-Vidal, C; Marco, F; Martínez, JA; Mensa, J; Morata, L; Soriano, A; Ternavasio-de la Vega, HG; Torres, A | 1 |
Aleva, RM; Boersma, WG; Bonten, MJ; Degener, JE; Jonkers, RE; Kullberg, BJ; Prins, JM; Sachs, APE; Schouten, JA; van de Garde, EMW; Verheij, TJ; Wiersinga, WJ | 1 |
Branislava, K; Niko, R; Nikola, S; Predrag, S; Stanković-Đorđević, D; Zorica, SR | 1 |
Bielicki, J; Fuchs, A; Mathur, S; Sharland, M; Van Den Anker, J | 1 |
Batard, E; Caruana, E; Chapelet, G; Goffinet, N; Javaudin, F; Kervagoret, E; Le Bastard, Q; Montassier, E | 1 |
Walker, MD | 1 |
Almirante, B; Burgos, J; Falcó, V | 1 |
Aliberti, S; Blasi, F; Di Pasquale, M; Gramegna, A; Mantero, M; Saderi, L; Sotgiu, G; Trogu, F | 1 |
Agüero Balbín, J; Angulo López, I; Calvo Montes, J; Crespo García, J; Fernández Torres, M; González Martinez, M; Rodríguez Lozano, J; Ruiz Bueno, P; Ruiz de Alegría Puig, C | 1 |
Anesi, JA; Bilker, WB; Dankwa, L; Garrigan, C; Han, JH; Lautenbach, E; Nachamkin, I; Omorogbe, J; Tolomeo, P; Wheeler, MK | 1 |
Berild, AG; Berild, D; Erichsen, D | 1 |
Armean, S; Behnke, M; Feihl, S; Gastmeier, P; Gebhardt, F; Hamprecht, A; Ihle, V; Kern, WV; Knobloch, JK; Kola, A; Mischnik, A; Obermann, B; Peter, S; Querbach, C; Rohde, AM; Schröder, W; Schwab, F; Seifert, H; Tacconelli, E; Vehreschild, MJGT; Wiese-Posselt, M; Zweigner, J | 1 |
Anesi, JA; Bilker, WB; Dankwa, L; Garrigan, C; Han, JH; Lautenbach, E; Nachamkin, I; Omorogbe, J; Tolomeo, P; Wheeler, M | 1 |
Engelhardt, M; Hamed, K; Santerre-Henriksen, A; Saulay, M; Scheeren, TWL; Welte, T | 1 |
Chang, SC; Chen, YC; Huang, YS; Lin, WP; Wang, JT | 1 |
Agnelli, F; Baratta, F; Colombo, F; Frantellizzi, V; Pani, A; Pastori, D; Scaglione, F | 1 |
Croxatto, A; Duss, FR; Garcia de la Mària, C; Giulieri, S; Lamoth, F; Manuel, O; Miró, JM | 1 |
Cantón, R; Díez-Aguilar, M; Morosini, MI | 1 |
Cillóniz, C; Dominedò, C; Garcia-Vidal, C; Torres, A | 1 |
Grau, S | 1 |
Bello, H; Domínguez, M; González, G; Mella, S; Riedel, G; Twele, L | 1 |
Flamm, RK; Jones, RN; Sader, HS | 1 |
Droz, S; Endimiani, A; Hilty, M; Kronenberg, A; Perreten, V; Seiffert, SN | 1 |
Frampton, JE | 1 |
Cha, MK; Chung, DR; Kang, CI; Kim, SH; Ko, KS; Lee, NY; Peck, KR; Song, JH; Wi, YM | 1 |
Baek, JY; Chung, DR; Kang, CI; Kim, SH; Ko, J; Lee, NY; Park, SY; Peck, KR; Song, JH | 1 |
Ambrose, PG; Bhavnani, SM; Forrest, A; Khariton, T; Reynolds, DK; Riccobene, T; Rubino, CM; Van Wart, SA | 1 |
Baserni, MN; Jugo, MB; Villar, HE | 1 |
Ambrose, PG; Bhavnani, SM; Forrest, A; Friedland, HD; Hammel, JP; Khariton, T; Reynolds, DK; Riccobene, TA; Rubino, CM; Van Wart, SA | 1 |
Chen, H; Li, H; Wang, H; Wang, Q; Wang, Z; Zhang, F; Zhao, C | 1 |
Carbonneau, M; Chang, HJ; Chaulk, J; Keough, A; Kumar, D; Ma, M; Qamar, H; Tandon, P | 1 |
Christiansen, KJ; Coombs, GW; Pearson, JC; Robinson, JO | 1 |
Auger, KA; Hall, M; Jerardi, KE; Myers, AL; Queen, MA; Shah, SS; Statile, AM; Tieder, JS; Williams, DJ | 1 |
Batard, E; Cousin, M; Goffinet, N; Hardouin, JB; Lecadet, N; Montassier, E; Peron, C | 1 |
Athan, E; De Almeida, M; Freeman, JT; Gunning, E; Havers, SM; Ingram, PR; Jones, M; Paterson, DL; Pitman, MC; Rogers, BA; Runnegar, N; Sidjabat, HE; Styles, K | 1 |
Barberino, MG; Berman, H; Moreira, ED; Reis, JN; Riley, L | 1 |
Bae, IK; Cho, YK; Hwang, SS; Jeong, SH; Kim, J; Kim, JM; Lee, K; Park, YS; Seo, YH | 1 |
Barber, KE; Barr, VO; Casapao, AM; Davis, SL; Goff, DA; Kaye, KS; Klinker, KP; Molloy, LM; Mynatt, RP; Pogue, JM; Rybak, MJ | 1 |
Blasi, F; Braido, F; Di Marco, F; Santus, P; Scichilone, N | 1 |
Eckburg, PB; Friedland, HD; Jandourek, A; Llorens, L; Smith, A; Thye, DA | 1 |
Cole, P; David Friedland, H; Evans, J; Jandourek, A; Ramani, A; Smith, A; Udeani, G | 1 |
Bei, D; Chen, Z; Dong, L; Fan, J | 1 |
Calbo, E; Zaragoza, R | 1 |
Chan, MC; Chang, FY; Lee, Y; Lin, JC; Lin, TY; Yang, YS; Yeh, KM | 1 |
Syed, YY | 1 |
Cheong, HJ; Cho, YK; Choi, TY; Chung, MH; Kang, JO; Ki, M; Kim, J; Kim, SJ; Kim, Y; Kwon, KT; Lee, H; Lee, JS; Lim, SK; Pai, H; Park, DW; Ryu, SY; Seo, MR; Wie, SH | 1 |
Cole, P; Evans, J; Friedland, HD; Udeani, G | 1 |
Cua, E; de Salvador, FG; Pradelli, J; Risso, K; Roger, PM; Ruimy, R | 1 |
Seifert, H | 1 |
Welte, T | 2 |
Cole, P; Friedland, HD; Maggiore, C; Pasquale, T | 1 |
Anzueto, AR; File, TM; Huang, X; Lodise, TP; Shorr, AF; Smith, A; Weber, DJ; Yang, M; Zhao, Q | 1 |
Chiang, CH; D'Souza, G; Iaconis, J; Lan, NH; Lee, SH; Melnick, D; Sun, F; Sun, T; Wilson, D; Zhong, NS; Zhuo, C | 1 |
Corey, GR; Jones, RN; Stryjewski, ME | 1 |
Cheng, J; Hou, X; Xu, Y; Xu, Z; Yang, Q; Zhang, H | 1 |
Canut, A; Isla, A; Rodríguez-Gascón, A | 1 |
Sadikot, RT; Swenson, CE | 1 |
Cao, B; Chen, R; Du, Y; Hu, B; Hu, Y; Liu, Y; Liu, Z; Su, D; Sun, H; Wang, H; Wang, Z; Xu, X; Zhang, F; Zhang, R; Zhao, C; Zhuo, C | 1 |
Cole, P; Friedland, HD; Guervil, DJ; Hassoun, A; Huang, XY; Kaye, KS | 1 |
Ensom, MH; Kiang, TK; Wilby, KJ | 1 |
Batard, E; Goffinet, N; Hardouin, JB; Lecadet, N; Lepelletier, D; Montassier, E; Potel, G | 1 |
Costello, AJ; Deshpande, LM; Farrell, DJ; Flamm, RK; Jones, RN; Mendes, RE | 1 |
Cillóniz, C; Liapikou, A; Torres, A | 1 |
Pawluk, SA; Wilby, KJ | 1 |
Melnick, D; Sun, T; Wilson, D; Zhong, NS | 1 |
Dare, CR; Gould, IM; Lawes, T; Lopez-Lozano, JM; Macartney, G; Nebot, CA; Subbarao-Sharma, R; Wares, KD | 1 |
File, TM; Friedland, HD; Iaconis, JP; Llorens, L; Melnick, D; Sun, F; Taboada, M; Wilson, D; Zhong, NS | 1 |
Chen, L; Chen, X; Jia, X; Li, N; Liu, W; Sun, H; Tong, H; Xiang, R; Xu, Y; Zhang, F; Zhang, J; Zhao, H | 1 |
Farrell, DJ; Flamm, RK; Jones, RN; Mendes, RE; Sader, HS | 1 |
Blumer, JL; Bradley, JS; Cannavino, C; Friedland, HD; Ghonghadze, T; Jandourek, A; O'Neal, T | 1 |
Bradley, JS; Cannavino, CR; Friedland, HD; Jandourek, A; Kaplan, SL; Korczowski, B; Nemeth, A; O'Neal, T | 1 |
Mouton, JW; Pea, F; Torres, A | 1 |
Flamm, RK; Jones, RN; Mendes, RE; Sader, HS | 1 |
Bijlsma, MW; Brouwer, MC; Costerus, JM; Tanck, MW; van de Beek, D; van der Ende, A | 1 |
Bradley, JS; Carrothers, TJ; Das, S; Jandourek, A; Khariton, T; Knebel, W; Li, J; Riccobene, TA | 1 |
Anesi, JA; Bilker, WB; Garrigan, C; Han, JH; Lautenbach, E; Nachamkin, I; Tolomeo, P; Wheeler, M | 1 |
Bamford, C; Buys, H; Eley, B; Muloiwa, R | 1 |
Scott, LJ | 1 |
Cantón, R; Díaz-Regañón, J; Livermore, DM; Morosini, MI; Rossolini, GM | 1 |
Hong, MY; Hsieh, CC; Hung, YP; Ko, WC; Lee, CC; Lee, CH; Lee, NY | 1 |
Hong, MY; Hsieh, CC; Hung, YP; Ko, WC; Lee, CC; Lee, CH; Tang, HJ; Wang, JL | 1 |
de la Uz, CM; Kim, JJ; Miyake, CY; Moffett, BS; Niu, MC; Valdés, SO | 1 |
El Hajj, MS; Turgeon, RD; Wilby, KJ | 1 |
Chang, FY; Chiu, CC; Hsiao, PJ; Lee, Y; Lin, JC; Lin, TC; Wu, RX; Yang, YS | 1 |
Danziger, LH; Glowacki, RC; Horn, KS; Rodvold, KA | 1 |
Cheung, CM; Leonard, SN; Rybak, MJ | 1 |
Bratzler, DW; Ma, A; Nsa, W | 1 |
Decker, CF; Johnson, MD | 1 |
Fadda, G; Mattina, R; Mezzatesta, ML; Nicoletti, G; Palù, G; Rossano, F; Schito, GC; Stefani, S; Tufano, MA | 1 |
Akalin, H; Gürcüoglu, E; Helvaci, S; Heper, Y; Kordan, Y; Mistik, R; Ozakin, C; Ozbey, S; Sinirtaş, M; Yilmaz, E | 1 |
Bianchetti, MG; Borsari, AG; Brazzola, P; Bucher, B; Dolina, M; Simonetti, GD | 1 |
Lortholary, O; Martin, C; Nordmann, P; Plesiat, P; Potel, G; Zahar, JR | 1 |
Ge, Y; Janes, R; Morrissey, I | 1 |
Marco, JA; Naranjo, OR; Rodríguez de Castro, F; Violán, JS | 1 |
Hoban, DJ; Karlowsky, JA; Nichol, K; Noreddin, AM; Voth, D; Zhanel, GG | 1 |
Aguilar, L; Coronel, P; Gimenez, MJ; Gimeno, M; Granizo, JJ; Prieto, J | 1 |
Gona, F; Marchese, G; Mezzatesta, ML; Nicoletti, G; Nicolosi, D; Stefani, S; Toscano, MA | 1 |
Starodubtseva, OI; Vakhrushev, IaM | 1 |
Barberán, J; Mensa, J | 1 |
Ahn, SB; Byun, TJ; Cho, HS; Eun, CS; Han, DS; Jeon, YC; Kang, JO; Kim, TY; Sohn, JH | 1 |
Gómez del Valle, C; Matía, M; Pérez-Calvo, JI; Torralba, MÁ | 1 |
Cheek, E; Citron, DM; Cubbon, M; Gerding, DN; Lippett, S; Llewelyn, M; Price, J; Sambol, SP | 1 |
Barahona C, F; González C, R; Saldías P, F; Sanhueza A, LM; Sepúlveda Z, F; Vásquez P, C | 1 |
Hedrick, JA | 1 |
Bongiorno, D; Borbone, S; Campanile, F; Stefani, S | 1 |
Bernard, E; Cua, E; De Salvador, F; Farhad, R; Pulcini, C; Rancurel, S; Roger, PM; Schiano, MH | 1 |
Chang, HH; Cheong, HS; Chung, DR; Heo, ST; Joung, MK; Jung, DS; Jung, SI; Ki, HK; Kim, SW; Kim, YS; Kwon, KT; Lee, H; Lee, JA; Lee, JS; Lee, SS; Moon, C; Moon, SY; Peck, KR; Rhee, JY; Ryu, SY; Shin, SY; Son, JS; Song, JH | 1 |
Bouza, E; Cercenado, E; Coronel, P; Cuevas, O; Gimeno, M; Marín, M | 1 |
Carlone, NA; Cocuzza, C; Furneri, PM; Musumeci, R; Nicoletti, G; Pilloni, AP; Prenna, M; Rigoli, R; Tempera, G; Tufano, MA; Tullio, V; Vitali, LA | 1 |
Hur, JK; Kang, JH; Kim, JH; Lee, KY; Lee, SY | 1 |
Critchley, I; Eckburg, PB; File, TM; Friedland, HD; Lee, J; Llorens, L; Low, DE; Talbot, GH; Thye, D | 1 |
Kanafani, ZA | 1 |
Boutbaoucht, M; Laghla, B; Nejmi, H; Samkaoui, MA | 1 |
Yu, VL | 1 |
Aguilar, L; Giménez, MJ; Soriano, F | 1 |
Cox, L; Hoban, DJ; Karlowsky, JA; Nichol, K; Noreddin, AM; Rossnagel, E; Zelenitsky, S; Zhanel, GG | 1 |
Johnson, LB; Saravolatz, LD; Stein, GE | 1 |
Critchley, IA; David Friedland, H; Eckburg, PB; File, TM; Lee, J; Llorens, L; Low, DE; Talbot, GH; Thye, DA | 1 |
Biek, D; Critchley, IA; Eckburg, PB; Friedland, HD; Jandourek, A; Thye, DA | 1 |
Critchley, IA; Eckburg, PB; File, TM; Friedland, HD; Lee, J; Llorens, L; Low, DE; Talbot, GH; Thye, DA | 1 |
Friedland, HD; Laudano, JB; Rank, DR | 1 |
Drusano, GL | 1 |
Farrell, DJ; Jones, RN; Mendes, RE; Sader, HS | 1 |
Bhattacharya, SS; Choudhury, BK; Das, U | 1 |
Johnson, AP; Leibovici, L | 1 |
Lanfranco, OA; Levine, DP | 1 |
Chen, LF; DiMondi, VP; Drew, RH | 1 |
Chun, BC; Eom, JS; Kim, EJ; Kim, MJ; Park, DW; Sohn, JW; Yoon, YK | 1 |
Alvarez-Espejo, T; Asensio, A; Bishopberger, C; Calbo-Torrecillas, F; Campayo, J; Canton, R; Fernandez-Crehuet, J; Hernandez Navarrete, M; Ramos, A; Vaque-Rafart, J | 1 |
Belavic, JM | 1 |
Carver, PL; DePestel, DD; Jorgenson, MR | 1 |
Amsler, K; Arbit, D; Balis, D; File, TM; Kaul, P; Michiels, B; Nicholson, SC; Noel, GJ; Strauss, RS; Welte, T | 1 |
Biek, D; Rybak, MJ; Steed, ME; Vidaillac, C; Winterfield, P | 1 |
Leakey, A; Morrissey, I | 1 |
Nikitin, AV | 1 |
Freeman, JT; Gamble, GD; Holland, DJ; McBride, SJ; Nisbet, MS; Taylor, SL; Williamson, DA | 1 |
Assoumou, MC; Boreux, R; De Mol, P; Gangoué-Piéboji, J; Lonchel, CM; Meex, C; Melin, P | 1 |
Cao, B; Chen, M; Chu, Y; Duan, Q; Hu, Y; Liu, Y; Sun, H; Sun, Z; Wang, H; Xu, Y; Yang, Q; Yu, Y; Zhang, R; Zhuo, C | 1 |
Casapao, AM; Levine, DP; Rybak, MJ; Steed, ME | 1 |
Arias, G; Buitrago, G; Castro, BE; Cortés, JA; Escobar, JA; Leal, AL; Ovalle, MV; Saavedra, SY | 1 |
Kariuki, S; Maina, D; Ozwara, H; Revathi, G | 1 |
Lodise, TP; Low, DE | 1 |
Farrell, DJ; Jones, RN; Pfaller, MA; Sader, HS | 1 |
Farrell, DJ; Flamm, RK; Jones, RN; Sader, HS | 2 |
Boutrad, Y; Crémieux, AC; Dinh, A; Dumitrescu, O; Etienne, J; Lina, G; Martin, E; Massias, L; Saleh-Mghir, A; Vandenesch, F | 1 |
DeBellis, HF; Jones, MC; Kincaid, SE | 1 |
Beraud, G; Cadranel, J; Godet, C | 1 |
Belabess, H; Honsali, Z; Jouhadi, Z; Lehlimi, M; Mdaghri, N; Najib, J; Sadiki, H; Zerouali, K | 1 |
Giuliano, C; Johnson, LB; Kale-Pradhan, PB | 1 |
Garrison, MW; Kawamura, NM; Wen, MM | 1 |
Boutbaoucht, M; Chabaa, L; Mouaffak, Y; Oulad Saiad, M; Salama, T; Soraa, N; Younous, S | 1 |
Eckburg, PB; Friedland, HD; Kollef, M; Llorens, L; Shorr, AF | 1 |
Brauers, J; Ewig, S; Kresken, M | 1 |
Balbisi, EA | 1 |
Badaró, R; Massud, J; Mendonça, J; Molinar, F; Nascimento, LO; Seas, C; Stamboulian, D | 1 |
Flamm, R; Hom, RC; LaFata, JA; le Roux, JG; Palo, WA; van Zyl, L; Volk, RS | 1 |
Craig, WA; Cyganowski, M; Fogarty, CM; Hom, RC; Palo, WA | 1 |
Burman, LG; Lagergren, A; Lidman, C; Ortqvist, A | 1 |
Ahlqvist, T; Augustinsson, A; Beckman, H; Blanck, C; Burman, LA; Claesson, B; Elbel, E; Erntell, M; Follin, P; Goscinski, G; Hedlund, J; Höfer, M; Holmberg, H; Jorup, C; Lidman, C; Lindhusen, E; Ortqvist, A; Qvarfordt, I; Rensfeldt, G; Rosenkvist, E; Stålberg, A; Stenlund, G; Verngren, K; Vig, I; Wendahl, S | 1 |
Aeberhard, P; Billing, A; Böcker, I; Gebhard, B; Ohmann, C; Röhrborn, A; Schäfer, V; Schöffel, U; Wacha, H | 1 |
Kataoka, S | 1 |
Uno, Y | 1 |
Odagiri, S; Shimada, J; Takahashi, H; Watanuki, Y | 1 |
Furukawa, M; Ito, M | 1 |
Iwata, T; Tajima, T | 1 |
Yokoyama, M | 1 |
Ubukata, K | 1 |
Sakata, H | 1 |
Ogata, H | 1 |
Suzuki, K | 1 |
Shibata, M | 1 |
Ito, M | 1 |
Gesser, RM; McCarroll, K; Teppler, H; Woods, GL | 1 |
Brown, RB; Gross, P; Iannini, P; Kunkel, M | 1 |
Fritsche, TR; Jones, RN; Mutnick, AH; Sader, HS | 1 |
Chapman, TM; Perry, CM | 1 |
Gupta, PK; Jain, N; Prasad, K; Singhal, T | 1 |
Chen, MJ; Hu, BJ; Li, HY; Liu, Y; Sun, ZY; Wang, H; Yu, YS | 1 |
Carlos, CC; Chang, HH; Chongthaleong, A; Jamal, F; Jung, SI; Kamarulzaman, A; Ki, HK; Kim, SW; Kim, YS; Ko, KS; Lalitha, MK; Lee, H; Oh, WS; Peck, KR; Perera, J; Shin, MH; So, T; Son, JS; Song, JH; Yee, TT | 1 |
Bourdin, A; Génin, R; Lilienthal, F; Lugagne, N; Paganin, F; Tixier, F; Yvin, JL | 1 |
Martin, DR; Plouffe, JF | 1 |
Biedenbach, DJ; Jones, RN; Sader, HS; Streit, JM | 1 |
Gao, L; Li, Y; Liu, J; Liu, Y; Lü, Y; Xiao, YH | 1 |
Deng, LP; Du, YP; Jiang, XT | 1 |
Daschner, FD; Ebner, W; Heininger, A; Meyer, E; Rüden, H; Schwab, F | 1 |
Erdem, H; Kiliç, S; Pahsa, A | 1 |
Epstein, BJ; Gums, JG | 1 |
Rumbaugh, JA; Sinha, G; Spalding, C; Speedie, A; Venkatesan, A | 1 |
Ivanov, DV; Sidorenko, SV | 1 |
Zubkov, MN | 1 |
Ikonomidis, A; Kristo, I; Maniatis, AN; Markogiannakis, A; Pournaras, S; Tsakris, A | 1 |
Appelbaum, PC | 1 |
Rice, LB | 1 |
Paterson, DL | 1 |
Kohlhammer, Y; Marre, R; Raspe, H; Schäfer, T; Suttorp, N; Welte, T | 1 |
Hedrick, J | 1 |
Bang, JW; Choe, KW; Kang, CI; Kim, EC; Kim, HB; Kim, NJ; Kim, SH; Oh, MD | 1 |
de Cueto, M; Hernández, JR; Muniain, MA; Navarro, MD; Pascual, A; Ríos, MJ; Rodríguez-Baño, J; Romero, L | 1 |
Bonten, MJ; Buskens, E; Hoepelman, AI; Hustinx, WM; Kaasjager, K; Kramer, MH; Lammers, JW; Oosterheert, JJ; Prins, JM; Schneider, MM; Slee, PH | 1 |
Lipman, J; Roberts, JA; Webb, SA | 1 |
Fritsche, TR; Jacobs, MR; Sader, HS | 1 |
Aguilar, L; Barberán, J; Coronel, P; Giménez, MJ; Gimeno, M; Granizo, JJ | 1 |
Bronze, MS; Cooper, TW; Gibbs, WJ; Greenfield, RA | 1 |
Kyrkovsky, V; Makarevich, A; Pancratova, J | 1 |
Chan, G; Mufson, MA; Stanek, RJ | 1 |
Blot, SI; Decruyenaere, JM; Depuydt, PO; Vandijck, DM | 1 |
Ellis, MW; Jorgensen, JH; Yun, HC | 1 |
Gupta, PK; Kumar, A; Prasad, K; Singhal, T | 1 |
Apisarnthanarak, A; Dejsirilert, S; Kiratisin, P; Kitphati, R; Mundy, LM; Saifon, P | 1 |
Adamcova, J; Bartkovjak, M; Benca, J; Deadline, J; Diana, E; Dudasova, T; Johnson, MJ; Juma, O; Kolenova, A; Muli, JM; Namulanda, V; Njambi, Z; Okoth, V; Pauerova, K; Polonova, J; Rabarova, L; Seckova, S; Sladeckova, V; Takacova, M; Taziarova, M | 1 |
Fritsche, TR; Jones, RN; Sader, HS | 1 |
Andreu, L; Cañizares, R; Cuadrado, JM; de la Tabla, VO; Jover, F; Martin, C; Martínez, S; Merino, J; Roig, P | 1 |
Biedenbach, DJ; Fritsche, TR; Jones, RN | 2 |
Laohavaleeson, S; Nicolau, DP; Tessier, PR | 1 |
Clynes, NE | 1 |
Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Oda, S; Shimada, J; Suzuki, Y; Yokota, N | 1 |
Ahkee, S; Huang, A; Raff, MJ; Ramirez, JA; Srinath, L | 1 |
Ortqvist, A | 2 |
Kumarasinghe, G; Lee, EJ; Leong, SO; Lye, WC | 1 |
Bertrand, A; Delaval, P; Depierre, A; Grès, JJ; Hughes, F; Léophonte, P; Lucht, F; Muir, JF; Nouvet, G; Ulmer, M | 1 |
Chen, ST; Tang, LM | 1 |
Deguchi, K; Fukayama, S; Fukumoto, T; Ishihara, R; Koguchi, M; Nakane, Y; Oda, S; Suzuki, Y; Tanaka, S; Yokota, N | 1 |
Gertner, J; Goldstein, FW; Péan, Y | 1 |
Ben Assuli, S; Hassin, D; Pitlik, S; Platau, E; Raz, R; Rosen, N; Rubinstein, E; Segev, S; Shmuely, H | 1 |
Boyter, A; Davey, P; Fegan, PG; Nathwani, D | 1 |
Belliveau, PP; Freeman, CD; Nicolau, DP; Nightingale, CH; Quintiliani, R; Tessier, PR | 1 |
Curran, R; Towner, KJ; Webster, CA | 1 |
Berk, SL; Kalbfleisch, JH | 1 |
Baños, V; Canteras, M; Gómez, J; Muñoz, L; Nuñez, ML; Ruiz Gómez, J; Soto, MC; Valdés, M | 1 |
Almenoff, PL; Cashin, R; Greene, JG; Halpern, NA; Lee, A; Siegel, RE | 1 |
Lee, SK; Ng, AW; Oh, HM | 1 |
Helwig, H | 1 |
Pellegrin, JL | 1 |
Bourrillon, A | 1 |
Brown, I; Feeney, R; Lovering, AM; MacGowan, AP; McCulloch, SY; Reeves, DS | 1 |
Chan, CH; Chan, TH; Ho, A; Lai, CK; Leung, R | 1 |
Collins, JJ; Feris, J; Giguere, G; Hidalgo, H; Higuera, F | 1 |
Huyghens, L; Lauwers, S; Meysman, M; Monsieur, I; Vincken, W | 1 |
Aufiero, A; Goglio, A; La Regina, A; Marruchella, A; Michetti, G; Nicolin, E; Sella, D; Silleni, M; Sturani, C; Zanon, P | 1 |
Gwaltney, JM; Keyserling, C; Leigh, A; Rivas, P; Savolainen, S; Scheld, WM; Schenk, P; Sydnor, A; Tack, KJ | 1 |
Bianchi, P; Drehobl, M; Griffin, TJ; Keyserling, CH; Tack, KJ | 1 |
Bouza, E; Lode, H; Mouton, Y; Wilson, WR | 1 |
Arata, J; Kawada, K; Saito, A; Sunakawa, K | 1 |
Holmes, C; Schlaeffer, F; Staley, H; Van den Brande, P; Vogel, F; Vondra, V | 1 |
Lim, TK | 1 |
Dunbar, L; File, TM; Kohler, R; Kojak, C; Player, R; Rubin, A; Segreti, J; Williams, RR | 1 |
Legnani, D; Quintiliani, R; Scaglione, F | 1 |
Deguchi, K; Ishihara, R; Ishii, Y; Nakazawa, A; Shimada, J; Suzuki, Y | 1 |
Butt, CJ; Palmer, KT; Rampling, A; Tully, M; West, AA | 1 |
Finch, RG; Gildon, KM; Pemberton, K | 1 |
Fraser, KL; Grossman, RF | 1 |
Deguchi, K; Ishihara, R; Ishii, Y; Nakazawa, A; Suzuki, Y; Toyonaga, Y | 1 |
Nelson, M; Zervos, M | 1 |
Paterson, DL; Playford, EG | 1 |
Felmingham, D; Grüneberg, RN; Harding, I; Robbins, MJ; Shrimpton, S; Tesfaslasie, Y | 1 |
Fachinelli, H; Kijanczuk, S; Mingrone, H; Salvarezza, CR | 1 |
Anderson, AN; Ebrahim, O; Wessels, F | 1 |
Rogers, TR; Wort, SJ | 1 |
Krone, LV | 1 |
Dvoretskiĭ, LI; Iakovlev, SV; Shakhova, TV; Suvorova, MP; Vlasenko, NA | 1 |
Dvoretskiĭ, LI; Omel'ianovskiĭ, VV | 1 |
Dvoretskiĭ, LI; Iakovlev, SV; Shakhova, TV; Suvorova, MP | 1 |
Ferguson, JK; Hensley, MJ | 1 |
Barrett, MS; Biedenbach, DJ; Croco, MA; Jones, RN | 1 |
Baños, V; Canteras, M; Gómez Vargas, J; Gómez, J; Muñoz, L; Ruiz Gómez, J; Sánchez, ME; Simarro, E; Soto, MC; Valdés, M | 1 |
Léophonte, P | 1 |
Parrish, AG | 1 |
Badenhorst, C; Barker, J; Patrick, H | 1 |
Norrby, SR; Petermann, W; Salewski, E; Vetter, N; Willcox, PA | 1 |
de Boisblanc, BP; Haponik, E; Karam, G; Nelson, S; Omidvari, K; Summer, W | 1 |
Kennedy, I | 1 |
Borja, J; Jané, F | 1 |
Asumang, A; Dryden, M; Goldsmith, AL | 1 |
Boulerice, F; Campbell, DA; Dubois, J; Garber, GE; Grossman, RF; Laforge, J; Landis, SJ; McIvor, RA; Murray, G; Rivard, M; Rotstein, C; Saginur, R; Stiver, HG | 1 |
Ewig, S; Marco, F; Martinez, JA; Mensa, J; Ruiz, M; Sanchez, M; Torres, A | 1 |
Hoshiai, M; Ishihara, T; Kanemura, H; Kitano, M; Mitsui, Y; Ohno, R; Toyonaga, Y | 1 |
Bonfitto, P; De Vietro, T; Lamorgese, V; Malerba, M; Rizzello, L; Scoditti, S; Zuin, R | 1 |
Endo, H; Ishihara, R; Ishii, Y; Matsumoto, Y; Nakane, Y; Nishinari, C; Suzuki, Y | 1 |
Belda, A; Gonzalvo, F; Martínez-Moragón, E; Pascual, JM; Ripollés, F; Rovira, E | 1 |
Petlak, A; Słomiński, JM; Wolska-Goszka, L | 1 |
Barrett, NL; Farley, MM; Feikin, DR; Harrison, LH; Jorgensen, JH; Kolczak, M; Lefkowitz, L; Lexau, C; McGeer, A; Patterson, JE; Schuchat, A; Stefonek, KR; Vugia, DJ | 1 |
Bates, J; File, TM; Grayston, JT; Indorf, A; Phillips, J; Sarosi, GA; Summersgill, J; Tan, J; Vergis, EN; YU, VL | 1 |
Feder, HM | 1 |
Chuang, YC; Ko, WC; Lee, HC; Liu, CC; Wu, JJ | 1 |
Fernández, P; San Martín, L | 1 |
Branch, RA; Coley, KC; Fine, MJ; Gleason, PP; Kapoor, W; Ryan, ML; Skledar, SJ; Yealy, DM | 1 |
See, S | 1 |
Ishii, Y; Miyazaki, S; Okamoto, H; Tateda, K; Yamaguchi, K | 1 |
Giamarellou, H | 1 |
Bell, T; Benenson, R; Kellogg, J; Manzella, J; Pellerin, G; Pope, D; Robertson, M | 1 |
Bagilet, D; Diab, M; Javkin, E; Kalbermatter, V | 1 |
Bogdanov, MB; Chernen'kaia, TV | 1 |
Desai, A; Mopkar, O; Rao, PP | 1 |
Carratalà, J; Dorca, J; Gudiol, F; Liñares, J; Manresa, F; Pallares, R; Rosón, B; Tubau, F | 1 |
Andresen, DN; Collignon, PJ | 1 |
Barnes, DJ; Dobbin, CJ; Duggan, CJ | 1 |
Dresser, LD; Niederman, MS; Paladino, JA | 1 |
Ambrose, PG; Nicolau, DP; Nightingale, CH; Owens, RC; Quintiliani, R; Tessier, P | 1 |
Alvarez-Lerma, F; Cerda, E; Olaechea, P; Palomar, M; Sierra, R | 1 |
Low, DE | 1 |
Adam, D | 1 |
García-Rodríguez, JA; Muñoz Bellido, JL | 1 |
Hamilton-Miller, JM | 1 |
Concia, E | 1 |
Chang, FY; Lin, JC; Peng, MY; Yeh, KM | 1 |
Kobashi, Y; Matsushima, T; Okimoto, N; Soejima, R | 1 |
Kalich, S; Nilsson-Ehle, I; Nord, CE; Ochs, HR; Odenholt, I; Vogel, F; Wettich, K | 1 |
Alegre-Martin, J; Odenholt, I; Petermann, W; Phillips, MJ; Tack, K; Trostmann, U; Welling, L; Willcox, PA | 1 |
Chen, Y; Hao, F; Li, J; Zhang, Y | 1 |
Amores, R; Calvo, A; Prieto, J; Sevillano, D; Valero, E | 1 |
Budanov, SV | 1 |
Caballero-Lopez, J; Carides, A; Friedland, IR; Ortiz-Ruiz, G; Woods, GL | 1 |
Figgitt, DP; Lamb, HM; Ormrod, D; Scott, LJ | 1 |
Kohlhepp, WC | 1 |
73 review(s) available for cephalosporin c and Community Acquired Infection
Article | Year |
---|---|
Ceftaroline.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Humans; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Staphylococcus aureus | 2021 |
Treatment outcomes of secondary bacteraemia in patients treated with ceftaroline fosamil: pooled results from six phase III clinical trials.
Topics: Adult; Bacteremia; Ceftaroline; Cephalosporins; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Humans; Pneumonia; Soft Tissue Infections; Treatment Outcome | 2022 |
Ceftaroline: Systematic Review of Clinical Uses and Emerging Drug Resistance.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Daptomycin; Drug Resistance; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2022 |
Ceftobiprole medocaril.
Topics: Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Humans; Methicillin-Resistant Staphylococcus aureus | 2022 |
Ceftaroline in severe community-acquired pneumonia.
Topics: Ceftaroline; Cephalosporins; Community-Acquired Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Pneumonia | 2022 |
Ceftaroline fosamil as a potential treatment option for Staphylococcus aureus community-acquired pneumonia in adults.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Drug-Related Side Effects and Adverse Reactions; Humans; Pneumonia, Staphylococcal; Staphylococcus aureus; Treatment Outcome | 2019 |
Current Clinical Trials on the Use of Ceftaroline in the Pediatric Population.
Topics: Adult; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Child; Community-Acquired Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Sepsis; Streptococcus pneumoniae | 2017 |
[Cefditoren: a reality for the treatment of community infections].
Topics: Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Humans | 2017 |
Are third-generation cephalosporins still the empirical antibiotic treatment of community-acquired spontaneous bacterial peritonitis? A systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Liver Cirrhosis; Opportunistic Infections; Peritonitis | 2018 |
Antibiotic use for community-acquired pneumonia in neonates and children: WHO evidence review.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Guidelines as Topic; Humans; Infant; Infant, Newborn; Pneumonia, Bacterial; World Health Organization | 2018 |
Ceftobiprole medocaril for the treatment of community-acquired pneumonia.
Topics: Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Bacterial | 2018 |
Efficacy and effectiveness of Ceftaroline Fosamil in patients with pneumonia: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Clinical Trials as Topic; Community-Acquired Infections; Cross Infection; Humans; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Retrospective Studies; Treatment Outcome | 2018 |
Off-label use of ceftaroline fosamil: A systematic review.
Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Community-Acquired Infections; Cross Infection; Endocarditis, Bacterial; Healthcare-Associated Pneumonia; Humans; Meningitis; Off-Label Use | 2019 |
Mechanisms of action and antimicrobial activity of ceftobiprole.
Topics: Aminoacyltransferases; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporins; Community-Acquired Infections; Endopeptidases; Enterobacteriaceae; Enterococcus; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Methicillin-Resistant Staphylococcus aureus; Penicillin Resistance; Penicillin-Binding Proteins; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Streptococcus pneumoniae | 2019 |
Ceftobiprole for the treatment of pneumonia.
Topics: Anti-Bacterial Agents; Cephalosporins; Clinical Trials as Topic; Community-Acquired Infections; Critical Illness; Cross Infection; Drug Administration Schedule; Humans; Pneumonia, Bacterial; Renal Insufficiency | 2019 |
Safety and tolerability of ceftobiprole.
Topics: Administration, Intravenous; Anti-Bacterial Agents; Cephalosporins; Clinical Trials, Phase I as Topic; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Cross Infection; Humans; Methicillin-Resistant Staphylococcus aureus; Neutropenia; Pneumonia, Bacterial; Pseudomonas aeruginosa; Streptococcus pneumoniae | 2019 |
Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Humans; Pneumonia; Skin Diseases, Infectious; Soft Tissue Infections | 2013 |
The role of cefditoren in the treatment of lower community-acquired respiratory tract infections (LRTIs): from bacterial eradication to reduced lung inflammation and epithelial damage.
Topics: Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Disease Eradication; Disease Progression; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive | 2014 |
Ceftobiprole medocaril: a review of its use in patients with hospital- or community-acquired pneumonia.
Topics: Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Cross Infection; Drug Approval; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Pneumonia, Bacterial; Prodrugs | 2014 |
Ceftaroline: clinical and microbiology experience with focus on methicillin-resistant Staphylococcus aureus after regulatory approval in the USA.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Drug Approval; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Product Surveillance, Postmarketing; Soft Tissue Infections; Staphylococcal Infections; Treatment Outcome; United States | 2015 |
Achromobacter respiratory infections.
Topics: Achromobacter; Age Factors; Anti-Bacterial Agents; Bronchiectasis; Cefoperazone; Cephalosporins; Community-Acquired Infections; Comorbidity; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Male; Neoplasms; Penicillins; Piperacillin; Pneumonia, Bacterial; Respiratory Tract Infections; Risk Factors; Sex Factors; Ticarcillin; Virulence Factors | 2015 |
A critical review on the clinical pharmacokinetics, pharmacodynamics, and clinical trials of ceftaroline.
Topics: Administration, Intravenous; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Clinical Trials as Topic; Community-Acquired Infections; Drug Administration Schedule; Humans; Pneumonia; Precision Medicine; Skin Diseases, Infectious | 2015 |
Ceftobiprole for the treatment of pneumonia: a European perspective.
Topics: Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Cross Infection; Europe; Humans; Pneumonia, Bacterial; Treatment Outcome | 2015 |
Ceftaroline fosamil versus ceftriaxone for the treatment of community-acquired pneumonia: individual patient data meta-analysis of randomized controlled trials.
Topics: Anti-Bacterial Agents; Ceftaroline; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Humans; Pneumonia, Bacterial; Randomized Controlled Trials as Topic | 2016 |
Pharmacokinetics and Dosing of Ceftobiprole Medocaril for the Treatment of Hospital- and Community-Acquired Pneumonia in Different Patient Populations.
Topics: Anti-Bacterial Agents; Area Under Curve; Cephalosporins; Community-Acquired Infections; Critical Illness; Cross Infection; Dose-Response Relationship, Drug; Drug Dosage Calculations; Half-Life; Humans; Infusions, Intravenous; Metabolic Clearance Rate; Microbial Sensitivity Tests; Monte Carlo Method; Pediatrics; Pneumonia; Renal Insufficiency | 2016 |
Ceftaroline Fosamil: A Review in Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia.
Topics: Animals; Ceftaroline; Cephalosporins; Clinical Trials as Topic; Community-Acquired Infections; Humans; Pneumonia; Soft Tissue Infections; Staphylococcal Skin Infections | 2016 |
Ceftaroline fosamil for community-acquired pneumonia and skin and skin structure infections: a systematic review.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Humans; Pneumonia; Randomized Controlled Trials as Topic; Staphylococcal Skin Infections | 2017 |
Pharmacokinetic drug evaluation of ceftobiprole for the treatment of MRSA.
Topics: Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Critical Illness; Cross Infection; Humans; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Staphylococcal Infections | 2017 |
Antimicrobial agents in treatment of MRSA infections.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Clindamycin; Community-Acquired Infections; Daptomycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluoroquinolones; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tetracyclines; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Vancomycin | 2008 |
Addressing the challenge of extended-spectrum beta-lactamases.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome; Urinary Tract Infections | 2009 |
New antimicrobial molecules and new antibiotic strategies.
Topics: Acetamides; Anti-Infective Agents; beta-Lactams; Cephalosporins; Community-Acquired Infections; Drug Design; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ertapenem; Fluoroquinolones; Humans; Ketolides; Linezolid; Lipopeptides; Oxazolidinones; Pneumonia, Bacterial; Practice Guidelines as Topic | 2009 |
Safety profile of cefditoren. A pooled analysis of data from clinical trials in community-acquired respiratory tract infections.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Double-Blind Method; Female; Gastrointestinal Diseases; Humans; Male; Penicillins; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Superinfection; Vaginitis | 2009 |
[Cefditoren and community-acquired lower respiratory tract infections (corrected)].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Haemophilus Infections; Haemophilus influenzae; Humans; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae | 2009 |
Cefditoren in upper and lower community-acquired respiratory tract infections.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Respiratory Tract Infections | 2011 |
Ceftaroline: a novel cephalosporin with activity against methicillin-resistant Staphylococcus aureus.
Topics: Adult; Animals; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Clinical Trials as Topic; Community-Acquired Infections; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Rabbits; Staphylococcal Infections; Streptococcus pneumoniae | 2011 |
Review of ceftaroline fosamil microbiology: integrated FOCUS studies.
Topics: Anti-Bacterial Agents; Bacterial Infections; Ceftaroline; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Treatment Outcome | 2011 |
What are the properties that make an antibiotic acceptable for therapy of community-acquired pneumonia?
Topics: Anti-Bacterial Agents; Bacteria; Ceftaroline; Cephalosporins; Community-Acquired Infections; Hospitalization; Humans; Pneumonia, Bacterial | 2011 |
Ceftaroline fosamil: a novel broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus.
Topics: Animals; Ceftaroline; Cephalosporins; Clinical Trials as Topic; Community-Acquired Infections; Drug Evaluation, Preclinical; Humans; Methicillin-Resistant Staphylococcus aureus; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Staphylococcal Infections | 2011 |
[Ceftaroline fosamil, a broad spectrum cephalosporin antibiotic for the treatment of community-acquired pneumonia and complicated skin and skin structure infections].
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Humans; Pneumonia, Bacterial; Skin Diseases, Bacterial | 2011 |
Ceftaroline fosamil for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infection.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Pneumonia, Bacterial; Skin Diseases, Bacterial | 2012 |
Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Ceftaroline; Cephalosporins; Clinical Trials as Topic; Community-Acquired Infections; Double-Blind Method; Humans; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial | 2012 |
Ceftaroline fosamil: a new cephalosporin active against resistant Gram-positive organisms including MRSA.
Topics: Animals; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Clinical Trials as Topic; Community-Acquired Infections; Gram-Positive Bacteria; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rabbits; Staphylococcal Infections | 2012 |
Cefditoren, a new aminothiazolyl cephalosporin.
Topics: Acute Disease; Bacterial Infections; Bronchitis, Chronic; Cephalosporins; Clinical Trials as Topic; Community-Acquired Infections; Drug Interactions; Humans; Maxillary Sinusitis; Pharyngitis; Pneumonia, Bacterial; Skin Diseases, Bacterial | 2002 |
Cefepime: a review of its use in the management of hospitalized patients with pneumonia.
Topics: Cefepime; Cephalosporins; Community-Acquired Infections; Cross Infection; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial | 2003 |
Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis.
Topics: Acute Disease; Ampicillin; Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Community-Acquired Infections; Humans; Meningitis, Bacterial; Penicillins; Randomized Controlled Trials as Topic | 2004 |
Re-evaluation of the therapy of severe pneumonia caused by Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Community-Acquired Infections; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Macrolides; Pneumonia, Pneumococcal | 2004 |
Optimal pharmacological therapy for community-acquired pneumonia: the role of dual antibacterial therapy.
Topics: Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Humans; Macrolides; Pneumonia, Bacterial; Practice Guidelines as Topic; Randomized Controlled Trials as Topic | 2005 |
[Cephalosporins and community-acquired pneumonia: a choice alternative].
Topics: Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Pneumonia, Bacterial | 2005 |
MRSA--the tip of the iceberg.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Community-Acquired Infections; Gram-Positive Bacteria; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2006 |
Antimicrobial resistance in gram-positive bacteria.
Topics: Animals; beta-Lactamase Inhibitors; Cephalosporins; Community-Acquired Infections; Cross Infection; Drug Combinations; Drug Resistance, Bacterial; Enterococcus faecalis; Gastrointestinal Tract; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Methicillin Resistance; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin Resistance | 2006 |
Resistance in gram-negative bacteria: enterobacteriaceae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Resistance, Multiple; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Quinolones; Urinary Tract Infections | 2006 |
Cephalosporins for uncomplicated skin and skin structure infections in emerging community-acquired MRSA.
Topics: Adult; Cephalosporins; Child; Community-Acquired Infections; Humans; Methicillin Resistance; Skin Diseases, Bacterial; Staphylococcal Skin Infections | 2006 |
Cefepime versus ceftazidime: considerations for empirical use in critically ill patients.
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Community-Acquired Infections; Critical Illness; Cross Infection; Drug Resistance; Economics, Pharmaceutical; Humans; Pneumonia, Bacterial | 2007 |
Review of the spectrum and potency of orally administered cephalosporins and amoxicillin/clavulanate.
Topics: Amoxicillin-Potassium Clavulanate Combination; Cephalosporins; Community-Acquired Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Respiratory Tract Infections; Streptococcus pneumoniae | 2007 |
The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clin
Topics: Anti-Bacterial Agents; Bronchitis, Chronic; Cephalosporins; Clinical Trials as Topic; Community-Acquired Infections; Drug Administration Schedule; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Pneumococcal Infections; Pneumonia, Bacterial; Respiratory Tract Infections; Streptococcus pneumoniae; Treatment Outcome | 2006 |
Antimicrobial symposium. Part IV. Cephalosporins.
Topics: Anti-Infective Agents; Cephalosporins; Chlamydophila pneumoniae; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterococcus; Humans; Legionella pneumophila; Mycoplasma pneumoniae; Staphylococcus aureus; Staphylococcus epidermidis | 2006 |
Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis.
Topics: Acute Disease; Ampicillin; Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Community-Acquired Infections; Humans; Meningitis, Bacterial; Penicillins; Randomized Controlled Trials as Topic | 2007 |
Initial investigation and treatment of the patient with severe community-acquired pneumonia.
Topics: Cephalosporins; Community-Acquired Infections; Critical Care; Humans; Pneumonia; Risk; Treatment Outcome | 1994 |
Contemporary issues in the management of pediatric infections.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Patient Compliance; Penicillins; Tonsillitis; Urinary Tract Infections | 1997 |
The use of cefotaxime for the treatment of common infections: in vitro, pharmacokinetic and clinical considerations.
Topics: Adolescent; Adult; Cefotaxime; Cephalosporins; Child; Clinical Trials as Topic; Community-Acquired Infections; Cross Infection; Humans; Microbial Sensitivity Tests; Middle Aged | 1997 |
What new antibiotics to offer in the outpatient setting.
Topics: Ambulatory Care; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Humans; Macrolides; Pneumonia; Quinolones | 1998 |
Should third-generation cephalosporins be the empirical treatment of choice for severe community-acquired pneumonia in adults?
Topics: Adult; Australia; Cephalosporins; Community-Acquired Infections; Drug Resistance, Microbial; Drug Therapy, Combination; Drug Utilization; Emergency Treatment; Evidence-Based Medicine; Humans; Patient Selection; Pneumonia; Practice Patterns, Physicians'; Severity of Illness Index | 1998 |
Cost-effectiveness of ceftriaxone in the treatment of community-acquired pneumonia in adult hospital patients. A pharmaco-economic study based on a meta-analysis.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Community-Acquired Infections; Cost-Benefit Analysis; Drug Administration Schedule; Drug Therapy, Combination; Hospital Costs; Humans; Infant; Length of Stay; Odds Ratio; Pneumonia, Bacterial; Retrospective Studies; South Africa; Treatment Outcome | 1998 |
[Differential use of cephalosporins in treatment of upper and lower respiratory tract infections].
Topics: Administration, Oral; Age Factors; Aged; Biological Availability; Cephalosporins; Community-Acquired Infections; Cross Infection; Humans; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Respiratory Tract Infections | 1998 |
In-hospital management of adults who have community-acquired pneumonia.
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Diagnosis, Differential; Europe; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Patient Admission; Pneumonia, Bacterial; United States | 1999 |
The new oral cephalosporins in community-acquired infections.
Topics: Administration, Oral; Cellulitis; Cephalosporins; Community-Acquired Infections; Gonorrhea; Humans; Otitis Media; Pharyngitis; Pneumonia; Tonsillitis | 2000 |
New oral cephalosporins in pediatric community-acquired infections.
Topics: Administration, Oral; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Humans; Otitis Media; Sinusitis; Tonsillitis | 2000 |
Oral cephalosporins in uncomplicated urinary tract infections.
Topics: Administration, Oral; Adolescent; Adult; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Urinary Tract Infections | 2000 |
Overview of cefixime use in community-acquired infections.
Topics: Cefixime; Cephalosporins; Community-Acquired Infections; Escherichia coli Infections; Female; Haemophilus Infections; Humans; Male; Neisseriaceae Infections; Patient Compliance; Respiratory Tract Infections; Staphylococcal Infections; Streptococcal Infections; Urinary Tract Infections | 2000 |
Role of parenteral cephalosporins in community-acquired lower respiratory tract infections.
Topics: Cephalosporins; Community-Acquired Infections; Drug Resistance, Microbial; Gram-Negative Bacterial Infections; Humans; Injections, Intravenous; Italy; Respiratory Tract Infections | 2000 |
[Start treatment of community-acquired pneumonia in outpatients and in hospitalized patients].
Topics: Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Hospitalization; Humans; Macrolides; Pneumonia; Staphylococcus | 2001 |
Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections.
Topics: Animals; Bacteria; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Cross Infection; Humans | 2002 |
Community-acquired pneumonia: cause and care.
Topics: Cephalosporins; Community-Acquired Infections; Humans; Macrolides; Patient Education as Topic; Pneumococcal Vaccines; Pneumonia; Practice Guidelines as Topic | 2002 |
68 trial(s) available for cephalosporin c and Community Acquired Infection
Article | Year |
---|---|
Pharmacokinetics and Safety of Ceftobiprole in Pediatric Patients.
Topics: Administration, Intravenous; Adolescent; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Data Analysis; Female; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Pneumonia | 2021 |
A
Topics: Asia, Eastern; Cephalosporins; Community-Acquired Infections; Cross Infection; Humans; Pneumonia, Bacterial | 2021 |
Early improvement in severely ill patients with pneumonia treated with ceftobiprole: a retrospective analysis of two major trials.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Cross Infection; Female; Humans; Linezolid; Male; Middle Aged; Pneumonia; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2019 |
Population pharmacokinetics of ceftaroline in patients with acute bacterial skin and skin structure infections or community-acquired bacterial pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Female; Humans; Infusions, Intravenous; Injections, Intramuscular; Male; Middle Aged; Models, Biological; Pneumonia, Bacterial; Skin Diseases, Bacterial; Young Adult | 2013 |
Pharmacokinetic-pharmacodynamic analyses for efficacy of ceftaroline fosamil in patients with community-acquired bacterial pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Female; Humans; Male; Middle Aged; Pneumonia; Young Adult | 2013 |
Efficacy of ceftaroline fosamil for bacteremia associated with community-acquired bacterial pneumonia.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Ceftaroline; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Treatment Outcome | 2014 |
Assessment of time to clinical response, a proxy for discharge readiness, among hospitalized patients with community-acquired pneumonia who received either ceftaroline fosamil or ceftriaxone in two phase III FOCUS trials.
Topics: Adult; Aged; Anti-Bacterial Agents; Ceftaroline; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Treatment Outcome | 2015 |
Ceftaroline fosamil versus ceftriaxone for the treatment of Asian patients with community-acquired pneumonia: a randomised, controlled, double-blind, phase 3, non-inferiority with nested superiority trial.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Asian People; Ceftaroline; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Female; Humans; Male; Middle Aged; Pneumonia; Treatment Outcome | 2015 |
A Multicenter, Randomized, Observer-blinded, Active-controlled Study Evaluating the Safety and Effectiveness of Ceftaroline Compared With Ceftriaxone Plus Vancomycin in Pediatric Patients With Complicated Community-acquired Bacterial Pneumonia.
Topics: Adolescent; Anti-Bacterial Agents; Ceftaroline; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Female; Humans; Infant; Infusions, Intravenous; Male; Pneumonia, Bacterial; Treatment Outcome; Vancomycin | 2016 |
A Randomized, Prospective Study of Pediatric Patients With Community-acquired Pneumonia Treated With Ceftaroline Versus Ceftriaxone.
Topics: Adolescent; Anti-Bacterial Agents; Ceftaroline; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Female; Hospitalization; Humans; Infant; Infusions, Intravenous; Male; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Bacterial; Prospective Studies; Staphylococcus aureus; Treatment Outcome | 2016 |
Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftaroline; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pneumonia, Bacterial; Treatment Outcome | 2010 |
FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.
Topics: Aged; Aged, 80 and over; Bacteria; Ceftaroline; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pneumonia, Bacterial; Treatment Outcome | 2011 |
Review of ceftaroline fosamil microbiology: integrated FOCUS studies.
Topics: Anti-Bacterial Agents; Bacterial Infections; Ceftaroline; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Treatment Outcome | 2011 |
FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.
Topics: Aged; Aged, 80 and over; Bacteria; Ceftaroline; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pneumonia, Bacterial; Treatment Outcome | 2011 |
Integrated safety summary of FOCUS 1 and FOCUS 2 trials: Phase III randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with community-acquired pneumonia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftaroline; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pneumonia, Bacterial | 2011 |
Ceftaroline fosamil for treatment of community-acquired pneumonia: findings from FOCUS 1 and 2 and potential role in therapy.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Ceftaroline; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Europe; Female; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Treatment Outcome; United States | 2011 |
A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Disease Eradication; Double-Blind Method; Drug Therapy, Combination; Female; Hospitalization; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Treatment Outcome; Young Adult | 2012 |
Assessment of ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia due to Streptococcus pneumoniae: insights from two randomized trials.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Ceftaroline; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Female; Humans; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Odds Ratio; Pneumonia, Pneumococcal; Retrospective Studies; Treatment Outcome | 2013 |
A multicenter comparative study of cefepime versus broad-spectrum antibacterial therapy in moderate and severe bacterial infections.
Topics: Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Cefepime; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Peritonitis; Pneumonia, Bacterial; Prospective Studies; Sepsis; Severity of Illness Index; South America; Treatment Outcome; Urinary Tract Infections | 2002 |
Cefditoren pivoxil versus cefpodoxime proxetil for community-acquired pneumonia: results of a multicenter, prospective, randomized, double-blind study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Child; Community-Acquired Infections; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Pneumococcal; Prospective Studies; South Africa; Streptococcus pneumoniae; Treatment Outcome; United States | 2002 |
A comparison of cefditoren pivoxil and amoxicillin/ clavulanate in the treatment of community-acquired pneumonia: a multicenter, prospective, randomized, investigator-blinded, parallel-group study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Child; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Pneumococcal; Prospective Studies; Researcher-Subject Relations; Streptococcus pneumoniae; Treatment Outcome; United States | 2002 |
Coverage of enterococci in community acquired secondary peritonitis: results of a randomized trial.
Topics: Adult; Aged; Cephalosporins; Community-Acquired Infections; Digestive System Surgical Procedures; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Penicillins; Peritonitis; Postoperative Complications; Prospective Studies; Reoperation; Sepsis; Surgical Wound Infection | 2000 |
[Clinical isolates and treatment of acute otitis media].
Topics: Acute Disease; Adolescent; Adult; Aged; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Bacterial; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Male; Middle Aged; Otitis Media; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae; Treatment Outcome | 2001 |
[Eradication of bacteria in upper pharynx of children treated with antibiotics].
Topics: Amoxicillin; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Penicillin Resistance; Pharyngitis; Pharynx; Pneumococcal Infections; Streptococcus pneumoniae; Treatment Outcome | 2001 |
[Mid term report of the CDTR clinical trial for PRSP and BLNAR infections].
Topics: Acute Disease; Ampicillin Resistance; beta-Lactamases; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Otitis Media; Penicillin Resistance; Pneumococcal Infections; Prospective Studies; Respiratory Tract Infections; Streptococcus pneumoniae; Treatment Outcome | 2001 |
[Efficacy and safety of twice-daily administration of CTDR].
Topics: Anti-Bacterial Agents; Cephalosporins; Child, Preschool; Community-Acquired Infections; Drug Resistance, Bacterial; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Patient Compliance; Pneumococcal Infections; Streptococcus pneumoniae; Treatment Outcome | 2001 |
[Isolation of bacteria and treatment of patients with pneumococcal and Haemophilus influenzae infections].
Topics: Adolescent; Adult; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Male; Middle Aged; Otorhinolaryngologic Diseases; Pneumococcal Infections; Streptococcus pneumoniae; Treatment Outcome | 2001 |
Efficacy of ertapenem in the treatment of serious infections caused by Enterobacteriaceae: analysis of pooled clinical trial data.
Topics: Adult; Aged; beta-Lactams; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Enterobacteriaceae Infections; Ertapenem; Escherichia coli Infections; Humans; Lactams; Middle Aged; Multicenter Studies as Topic; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome; Urinary Tract Infections | 2003 |
[Comparative study on cefdinir and cefaclor in the treatment of patients with mild to moderate bacterial community acquired pneumonia].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cephalosporins; Community-Acquired Infections; Humans; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Single-Blind Method; Staphylococcal Infections; Streptococcal Infections | 2004 |
Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Clavulanic Acid; Community-Acquired Infections; Drug Combinations; Humans; Infusions, Intravenous; Middle Aged; Pneumonia, Bacterial; Time Factors; Treatment Outcome | 2006 |
The effect of extracorporeal efferent detoxication (EED) methods inclusion in the severe community-acquired pneumonia (CAP) treatment.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cephalosporins; Combined Modality Therapy; Community-Acquired Infections; Drug Administration Routes; Female; Humans; Lipid Peroxidation; Lymphocytes; Male; Middle Aged; Pneumonia; Sorption Detoxification; Treatment Outcome; Ultraviolet Rays | 2006 |
[Clinical and bacteriological effects of cefetamet pivoxil against community-acquired respiratory tract infections].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; Ceftizoxime; Cephalosporins; Community-Acquired Infections; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Respiratory Tract Infections; Tablets | 1995 |
Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Cephalosporins; Community-Acquired Infections; Hospitalization; Humans; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Pneumonia; Time Factors; Treatment Outcome | 1995 |
A comparative study of cefepime and ceftazidime in the treatment of community-acquired lower respiratory tract infections.
Topics: Adult; Aged; Aged, 80 and over; Bacteria; Cefepime; Ceftazidime; Cephalosporins; Community-Acquired Infections; Female; Follow-Up Studies; Humans; Injections, Intramuscular; Injections, Intravenous; Male; Middle Aged; Radiography; Respiratory Tract Infections | 1993 |
Double-blind randomized study of 1 g versus 2 g intravenous ceftriaxone daily in the therapy of community-acquired infections.
Topics: Adult; Aged; Aged, 80 and over; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Female; Humans; Injections, Intravenous; Male; Middle Aged; Prospective Studies | 1995 |
Serum bactericidal activity of ceftizoxime and ceftriaxone against pathogens associated with community-acquired and nosocomial pneumonias.
Topics: Adolescent; Adult; Ceftizoxime; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Cross Infection; Cross-Over Studies; Female; Humans; Male; Pneumonia, Bacterial; Prospective Studies; Serum Bactericidal Test | 1996 |
A prospective randomized study of inpatient iv. antibiotics for community-acquired pneumonia. The optimal duration of therapy.
Topics: Adult; Aged; Cefuroxime; Cephalosporins; Community-Acquired Infections; Cost-Benefit Analysis; Female; Humans; Length of Stay; Male; Middle Aged; Pneumonia; Prospective Studies; Time Factors | 1996 |
Cefuroxime compared to amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia.
Topics: Administration, Oral; Adult; Amoxicillin; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Community-Acquired Infections; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Injections, Intravenous; Male; Middle Aged; Penicillins; Pneumonia, Bacterial; Treatment Outcome | 1996 |
Hospitalized patients with community-acquired pneumonia in Hong Kong: a randomized study comparing imipenem/cilastatin and ceftazidime.
Topics: Adult; Aged; Ceftazidime; Cephalosporins; Cilastatin; Community-Acquired Infections; Drug Therapy, Combination; Female; Follow-Up Studies; Hong Kong; Hospitalization; Humans; Imipenem; Injections, Intravenous; Male; Pneumonia, Bacterial; Protease Inhibitors; Survival Rate; Thienamycins | 1997 |
Comparison of oral cefuroxime axetil and oral amoxycillin/clavulanate in the treatment of community-acquired pneumonia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefuroxime; Cephalosporins; Child; Clavulanic Acids; Community-Acquired Infections; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Prodrugs; Prospective Studies; Treatment Outcome | 1996 |
Cefepime versus ceftazidime in the treatment of lower respiratory tract infections.
Topics: Aged; Cefepime; Ceftazidime; Cephalosporins; Community-Acquired Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Respiratory Tract Infections | 1997 |
Comparative effectiveness and safety of cefdinir and amoxicillin-clavulanate in treatment of acute community-acquired bacterial sinusitis. Cefdinir Sinusitis Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; Cefdinir; Cephalosporins; Child; Clavulanic Acids; Community-Acquired Infections; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Single-Blind Method; Sinusitis; Treatment Outcome | 1997 |
Comparison of cefdinir and cefaclor in treatment of community-acquired pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefaclor; Cefdinir; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Treatment Outcome; United States | 1997 |
Sequential therapy with cefuroxime followed by cefuroxime axetil in community-acquired pneumonia.
Topics: Administration, Oral; Cefuroxime; Cephalosporins; Community-Acquired Infections; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Male; Middle Aged; Pneumonia, Bacterial; Prodrugs; Prospective Studies; Treatment Outcome | 1997 |
A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ceftriaxone; Cefuroxime; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Prodrugs; Prospective Studies; Treatment Outcome | 1997 |
[Clinical and bacteriological effects of cefetamet pivoxil against community-acquired respiratory tract infections. Part II].
Topics: Adult; Aged; Bacteria; Bacterial Infections; Ceftizoxime; Cephalosporins; Community-Acquired Infections; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Respiratory Tract Infections | 1997 |
Pneumonia: the impact of risk factors on the outcome of treatment with meropenem and ceftazidime.
Topics: Adolescent; Adult; Age Factors; Aged; Ceftazidime; Cephalosporins; Community-Acquired Infections; Female; Humans; Intensive Care Units; Male; Meropenem; Middle Aged; Pneumonia, Bacterial; Respiration, Artificial; Risk Factors; Sex Factors; Thienamycins; Treatment Outcome | 1998 |
Cefepime versus ceftriaxone for empiric treatment of hospitalized patients with community-acquired pneumonia. The Cefepime Study Group.
Topics: Cefepime; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Female; Humans; Male; Middle Aged; Pneumonia | 1998 |
Comparison of roxithromycin with cefixime in the treatment of adults with community-acquired pneumonia.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Cefotaxime; Cephalosporins; Community-Acquired Infections; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Roxithromycin; Streptococcus pneumoniae | 1998 |
[Stepwise therapy of community-acquired pneumonia. Results of cefuroxime and cefuroxime axetil study].
Topics: Administration, Oral; Adolescent; Adult; Aged; Cefuroxime; Cephalosporin Resistance; Cephalosporins; Chromatography, High Pressure Liquid; Community-Acquired Infections; Drug Administration Schedule; Female; Humans; Injections, Intraperitoneal; Male; Middle Aged; Pneumonia, Bacterial; Prodrugs; Treatment Outcome | 1998 |
[Program of empirical antibacterial therapy of community-acquired pneumonia].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Ceftibuten; Cefuroxime; Cephalosporins; Community-Acquired Infections; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Male; Middle Aged; Pefloxacin; Pneumonia, Bacterial; Roxithromycin; Spiramycin | 1998 |
[Prospective and comparative study between cefuroxime, ceftriaxone and amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Ceftriaxone; Cefuroxime; Cephalosporins; Child; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies | 1998 |
A comparative study of levofloxacin and ceftriaxone in the treatment of hospitalized patients with pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospitalization; Humans; International Cooperation; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Treatment Outcome | 1998 |
Early transition to oral antibiotic therapy for community-acquired pneumonia: duration of therapy, clinical outcomes, and cost analysis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Cefaclor; Cefamandole; Cephalosporins; Community-Acquired Infections; Female; Health Care Costs; Hospitalization; Humans; Injections, Intravenous; Length of Stay; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome | 1998 |
Treatment of community-acquired pneumonia in the elderly: the role of cefepime, a fourth-generation cephalosporin.
Topics: Aged; Aged, 80 and over; Cefepime; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Female; Humans; Male; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome | 1999 |
[Clinical and bacteriological evaluation of ceftriaxone (CTRX) dosed once daily in children with community-acquired pneumonia].
Topics: Ceftriaxone; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Microbial; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Infusions, Intravenous; Male; Pneumonia, Bacterial; Streptococcal Infections; Streptococcus pneumoniae | 1999 |
A randomized trial of cefepime and ceftazidime for the treatment of community-acquired pneumonia.
Topics: Aged; Cefepime; Ceftazidime; Cephalosporins; Community-Acquired Infections; Drug Administration Schedule; Drug Costs; Female; Humans; Male; Middle Aged; Pneumonia; Treatment Outcome | 1999 |
Treatment of community-acquired pneumonia in outpatients: randomized study of clarithromycin alone versus clarithromycin and cefuroxime.
Topics: Adult; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Male; Pneumonia, Bacterial | 1999 |
Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial.
Topics: Anti-Bacterial Agents; Azithromycin; Cefuroxime; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Humans; Microbial Sensitivity Tests; Pneumonia; Prospective Studies | 2000 |
[Community acquired pneumonia: from intravenous to oral cephalosporin sequential therapy].
Topics: Administration, Oral; Aged; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Female; Humans; Injections, Intravenous; Male; Pneumonia; Prospective Studies; Treatment Outcome | 2000 |
Changing physician prescribing behavior: the community-acquired pneumonia intervention trial.
Topics: Aged; Anti-Infective Agents; Case-Control Studies; Cefuroxime; Cephalosporins; Community-Acquired Infections; Drug Prescriptions; Emergency Service, Hospital; Female; Hospitalization; Humans; Male; Physician's Role; Pneumonia; Severity of Illness Index | 2000 |
[Oral levofloxacin versus intravenous ceftriaxone and amoxicillin/clavulanic acid in the treatment of community-acquired pneumonia that requires hospitalization].
Topics: Administration, Oral; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Analysis of Variance; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia; Prospective Studies | 2000 |
Comparative trial to evaluate the efficacy and tolerability of cefuroxime 250mg with probenecid 250mg with cefuroxime 500mg in the management of community acquired pneumonia, acute bronchitis and acute exacerbation of chronic bronchitis.
Topics: Acute Disease; Adult; Bronchitis; Cefuroxime; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Male; Pneumonia; Probenecid; Prospective Studies | 2000 |
Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: a randomized study of amoxicillin-clavulanate and ceftriaxone.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactam Resistance; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillin G; Penicillins; Pneumonia, Bacterial; Streptococcus pneumoniae | 2001 |
Cost-effectiveness of gatifloxacin vs ceftriaxone with a macrolide for the treatment of community-acquired pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Cost-Benefit Analysis; Decision Trees; Double-Blind Method; Female; Fluoroquinolones; Gatifloxacin; Humans; Macrolides; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies | 2001 |
Pharmacodynamics of ceftriaxone and cefixime against community-acquired respiratory tract pathogens.
Topics: Administration, Oral; Adult; Blood Bactericidal Activity; Cefixime; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Cross-Over Studies; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Injections, Intramuscular; Injections, Intravenous; Male; Moraxella catarrhalis; Neisseriaceae Infections; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae | 2001 |
A prospective, randomized, multicenter comparative study of clinafloxacin versus a ceftriaxone-based regimen in the treatment of hospitalized patients with community-acquired pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Cross Infection; Drug Therapy, Combination; Erythromycin; Female; Fluoroquinolones; Humans; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome | 2001 |
A study evaluating the efficacy, safety, and tolerability of ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults.
Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Drug Tolerance; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome | 2002 |
213 other study(ies) available for cephalosporin c and Community Acquired Infection
Article | Year |
---|---|
Use of antibiotics and factors associated with treatment failure among 152,245 patients with pneumonia treated in the community - a retrospective cohort study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Fluoroquinolones; Humans; Israel; Male; Middle Aged; Penicillins; Pneumonia, Bacterial; Retrospective Studies; Treatment Failure | 2022 |
Association of antibiotic use and acute kidney injury in patients hospitalized with community-acquired pneumonia.
Topics: Acute Kidney Injury; Adolescent; Adult; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Female; Humans; Macrolides; Male; Piperacillin, Tazobactam Drug Combination; Pneumonia; Retrospective Studies; Vancomycin | 2022 |
Impact on in-hospital mortality of ceftaroline versus standard of care in community-acquired pneumonia: a propensity-matched analysis.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Female; Hospital Mortality; Humans; Male; Middle Aged; Retrospective Studies; Standard of Care; Staphylococcal Infections | 2022 |
Association of fluoroquinolones or cephalosporin plus macrolide with
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Clostridium Infections; Community-Acquired Infections; Fluoroquinolones; Humans; Macrolides; Pneumonia; Retrospective Studies | 2023 |
Prevalence, etiology and antibiotic resistance patterns of community-acquired urinary tract infections in Dhaka, Bangladesh.
Topics: Adult; Anti-Bacterial Agents; Bangladesh; Carbapenems; Cephalosporins; Coagulase; Community-Acquired Infections; Cross-Sectional Studies; Drug Resistance, Microbial; Enterococcus; Escherichia coli; Female; Fluoroquinolones; Humans; Klebsiella; Macrolides; Male; Penicillins; Prevalence; Urinary Tract Infections | 2022 |
Use of ceftaroline in complex central nervous system infections.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections | 2023 |
Activity of ceftaroline against pathogens associated with community-acquired pneumonia collected as part of the AWARE surveillance program, 2015-2016.
Topics: Anti-Bacterial Agents; Bacteria; Ceftaroline; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Pneumonia; Public Health Surveillance | 2019 |
Increased community-acquired upper urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in children and the efficacy of flomoxef and cefmetazole.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactamases; Cefmetazole; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Escherichia; Escherichia coli Infections; Escherichia coli Proteins; Female; Genotype; Humans; Infant; Infant, Newborn; Male; O Antigens; Retrospective Studies; Urinary Tract Infections; Virulence | 2019 |
Ceftaroline for treating older patients with community-acquired pneumonia.
Topics: Aged; Anti-Bacterial Agents; Ceftaroline; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Humans; Pneumonia | 2020 |
Ceftaroline for severe community-acquired pneumonia: A real-world two-centre experience in Italy and Spain.
Topics: Aged; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Female; Humans; Italy; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Oseltamivir; Pneumococcal Infections; Pneumonia; Retrospective Studies; Spain; Staphylococcal Infections; Streptococcus pneumoniae | 2020 |
Switching from intravenous to oral antibiotics in hospitalized patients with community-acquired pneumonia: A real-world analysis 2010-2018.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Female; Fluoroquinolones; Guideline Adherence; Hospitalization; Humans; Japan; Length of Stay; Male; Middle Aged; Penicillins; Pneumonia, Bacterial; Practice Guidelines as Topic; Practice Patterns, Physicians'; Retrospective Studies; Severity of Illness Index; Societies, Medical; Time Factors | 2020 |
Prevalence of fluoroquinolone-resistant and broad-spectrum cephalosporin-resistant community-acquired urinary tract infections in Rio de Janeiro: Impact of Escherichia coli genotypes ST69 and ST131.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Brazil; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Female; Fluoroquinolones; Genotype; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Prevalence; Urinary Tract Infections; Uropathogenic Escherichia coli; Young Adult | 2020 |
Emergence of Haemophilus parainfluenzae resistant to third-generation cephalosporins in Italy: potential role of PBP3 and PBP5 substitutions in high-level resistance.
Topics: Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Haemophilus Infections; Haemophilus parainfluenzae; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillin-Binding Proteins | 2020 |
Ceftobiprole and pneumonia in adults admitted to the emergency department is it time to assess a new therapeutic algorithm?
Topics: Aged; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Comorbidity; Emergency Service, Hospital; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Retrospective Studies; Severity of Illness Index | 2021 |
Model-Based Approach for Optimizing Ceftobiprole Dosage in Pediatric Patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Child; Community-Acquired Infections; Humans; Infant, Newborn; Infusions, Intravenous | 2021 |
Comparing the therapeutic efficacies of third-generation cephalosporins and broader-spectrum β-lactams as appropriate empirical therapy in adults with community-onset monomicrobial Enterobacteriaceae bacteraemia: a propensity score matched analysis.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cephalosporins; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Propensity Score; Treatment Outcome | 2017 |
Ceftaroline Activity Tested Against Bacterial Isolates Causing Community-acquired Respiratory Tract Infections and Skin and Skin Structure Infections in Pediatric Patients From United States Hospitals: 2012-2014.
Topics: Adolescent; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Haemophilus influenzae; Hospitals; Humans; Infant; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Respiratory Tract Infections; Retrospective Studies; Skin Diseases, Bacterial; Staphylococcal Infections; Streptococcus pneumoniae; United States | 2017 |
Macrolide therapy for community-acquired pneumonia due to atypical pathogens: outcome assessment at an early time point.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftaroline; Ceftriaxone; Cephalosporins; Chlamydial Pneumonia; Chlamydophila pneumoniae; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Legionella pneumophila; Macrolides; Male; Middle Aged; Mycoplasma pneumoniae; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome | 2017 |
Early Use of Ceftaroline Fosamil in the United States Veterans Health Care System.
Topics: Aged; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Epidemiologic Studies; Female; Humans; Male; Middle Aged; United States; Veterans Health | 2017 |
Identification and determination of related substances of ceftaroline fosamil in medicinal product by high performance liquid chromatography with diode array detection and tandem mass spectrometry.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Chromatography, High Pressure Liquid; Community-Acquired Infections; Tandem Mass Spectrometry | 2017 |
Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients.
Topics: Abdomen; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; China; Community-Acquired Infections; Cross Infection; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Incidence; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2017 |
Effectiveness of combination therapy versus monotherapy with a third-generation cephalosporin in bacteraemic pneumococcal pneumonia: A propensity score analysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Female; Hospitalization; Humans; Macrolides; Male; Middle Aged; Pneumonia, Pneumococcal; Propensity Score; Prospective Studies | 2018 |
Management of community-acquired pneumonia in adults: 2016 guideline update from the Dutch Working Party on Antibiotic Policy (SWAB) and Dutch Association of Chest Physicians (NVALT).
Topics: Adult; Anti-Bacterial Agents; Antigens, Bacterial; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Female; Humans; Male; Netherlands; Pneumonia; Practice Guidelines as Topic; Severity of Illness Index | 2018 |
Community-acquired Clostridium difficile infection in Serbian pediatric population.
Topics: Anti-Bacterial Agents; Case-Control Studies; Cephalosporins; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Community-Acquired Infections; Cross Infection; Diarrhea; Female; Humans; Infant; Male; Penicillins; Prospective Studies; Retrospective Studies; Risk Factors; Serbia | 2018 |
Are third-generation cephalosporins associated with a better prognosis than amoxicillin-clavulanate in patients hospitalized in the medical ward for community-onset pneumonia?
Topics: Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Female; Humans; Male; Pneumonia, Bacterial; Retrospective Studies | 2018 |
Leptospirosis: the possible risk to those participating in water-based sports and activities.
Topics: Athletes; Cephalosporins; Community-Acquired Infections; Environmental Exposure; Fever of Unknown Origin; Humans; Leptospirosis; Occupational Exposure; Penicillins; Primary Health Care; Risk Factors; Swimming; Travel; United Kingdom; Watchful Waiting | 2018 |
[Spontaneous bacterial peritonitis caused by Listeria monocytogenes: eight case reports (1992-2017) and literature review].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Female; Humans; Listeria monocytogenes; Listeriosis; Liver Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Peritonitis | 2018 |
Poor clinical outcomes associated with community-onset urinary tract infections due to extended-spectrum cephalosporin-resistant Enterobacteriaceae.
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporin Resistance; Cephalosporins; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Pennsylvania; Retrospective Studies; Risk Factors; Urinary Tract Infections | 2018 |
Treatment of community-acquired pneumonia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Female; Gentamicins; Guideline Adherence; Haemophilus Infections; Haemophilus influenzae; Humans; Length of Stay; Male; Middle Aged; Norway; Penicillins; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Practice Guidelines as Topic; Severity of Illness Index; Streptococcus pneumoniae; Time Factors | 2018 |
Incidence of infections due to third generation cephalosporin-resistant
Topics: Aged; Cephalosporins; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Germany; Hospitals, University; Humans; Incidence; Male; Middle Aged; Patient Admission; Prospective Studies | 2018 |
The role of extended-spectrum cephalosporin-resistance in recurrent community-onset Enterobacteriaceae urinary tract infections: a retrospective cohort study.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Cohort Studies; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Urinary Tract Infections | 2019 |
Prevalence of and risk factor for community-onset third-generation cephalosporin-resistant Escherichia coli bacteremia at a medical center in Taiwan.
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Hospitals; Humans; Prevalence; Risk Factors | 2019 |
Successful treatment with daptomycin and ceftaroline of MDR Staphylococcus aureus native valve endocarditis: a case report.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Daptomycin; Drug Synergism; Endocarditis; Fosfomycin; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections | 2019 |
[The pneumococcal connection].
Topics: Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Pneumococcal Infections; Streptococcus pneumoniae | 2013 |
Antimicrobial activity of ceftaroline and comparator agents tested against bacterial isolates causing skin and soft tissue infections and community-acquired respiratory tract infections isolated from the Asia-Pacific region and South Africa (2010).
Topics: Anti-Bacterial Agents; Asia; Ceftaroline; Cephalosporins; Community-Acquired Infections; Haemophilus influenzae; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Skin Diseases, Bacterial; Soft Tissue Infections; South Africa; Staphylococcus aureus; Streptococcus pneumoniae | 2013 |
Extended-spectrum cephalosporin-resistant Escherichia coli in community, specialized outpatient clinic and hospital settings in Switzerland.
Topics: Ambulatory Care Facilities; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Chromosomes; Cluster Analysis; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Genotype; Hospitals; Humans; Microarray Analysis; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA; Switzerland | 2013 |
Clinical and molecular epidemiology of community-onset bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli over a 6-year period.
Topics: Aging; Bacteremia; beta-Lactamases; Biliary Tract Diseases; Cephalosporin Resistance; Cephalosporins; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Prevalence; Retrospective Studies; Urinary Tract Infections | 2013 |
First imported case of skin infection caused by PVL-positive ST30 community-associated methicillin-resistant Staphylococcus aureus clone in a returning Korean traveler from the Philippines.
Topics: Adult; Bacterial Toxins; Carbuncle; Cephalosporins; Community-Acquired Infections; Exotoxins; Female; Humans; Leukocidins; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Philippines; Republic of Korea; Staphylococcal Skin Infections; Travel; Vancomycin | 2013 |
Faecal carriage of ESBL-producing Enterobacteriaceae and carbapenem-resistant Gram-negative bacilli in community settings.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Argentina; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Carrier State; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Feces; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Young Adult | 2013 |
In vitro antibacterial activities of two novel oral antibiotics, tebipenem and cefditoren, and other comparators against community-acquired respiratory tract infection-associated bacterial pathogens: a multicentre study in China.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Cephalosporins; China; Community-Acquired Infections; Humans; Microbial Sensitivity Tests; Respiratory Tract Infections | 2014 |
Third-generation cephalosporin-resistant spontaneous bacterial peritonitis: a single-centre experience and summary of existing studies.
Topics: Anti-Bacterial Agents; Bacterial Infections; Canada; Cephalosporin Resistance; Cephalosporins; Cohort Studies; Community-Acquired Infections; Cross Infection; Female; Humans; Liver Cirrhosis; Logistic Models; Male; Middle Aged; Multivariate Analysis; Peritonitis; Prevalence; Retrospective Studies | 2014 |
Activity of ceftaroline against community associated and healthcare associated methicillin resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Cross Infection; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections | 2014 |
Comparative effectiveness of empiric antibiotics for community-acquired pneumonia.
Topics: Adolescent; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Cohort Studies; Community-Acquired Infections; Comparative Effectiveness Research; Female; Fluoroquinolones; Hospitalization; Hospitals, Pediatric; Humans; Infant; Logistic Models; Macrolides; Male; Matched-Pair Analysis; Multivariate Analysis; Penicillins; Pneumonia; Propensity Score; Retrospective Studies; Treatment Outcome | 2014 |
Increasing use of third-generation cephalosporins for pneumonia in the emergency department: may some prescriptions be avoided?
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Emergency Medical Services; Emergency Service, Hospital; Female; Humans; Male; Pneumonia; Prohibitins; Retrospective Studies | 2014 |
Community-onset Escherichia coli infection resistant to expanded-spectrum cephalosporins in low-prevalence countries.
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Risk Factors | 2014 |
Distribution of strain type and antimicrobial susceptibility of Escherichia coli isolates causing meningitis in a large urban setting in Brazil.
Topics: Anti-Bacterial Agents; beta-Lactamases; Brazil; Cephalosporins; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Meningitis; Microbial Sensitivity Tests; Urinary Tract Infections | 2014 |
Risk factors and molecular epidemiology of community-onset extended-spectrum β-lactamase-producing Escherichia coli bacteremia.
Topics: Age Factors; Aged; Bacteremia; beta-Lactamases; Case-Control Studies; Cephalosporins; Community-Acquired Infections; Decision Making, Computer-Assisted; Escherichia coli; Escherichia coli Infections; Humans; Middle Aged; Molecular Epidemiology; Republic of Korea; Risk Factors; Tertiary Care Centers; Urinary Tract Infections | 2014 |
Large retrospective evaluation of the effectiveness and safety of ceftaroline fosamil therapy.
Topics: Aged; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Retrospective Studies; Skin Diseases, Bacterial | 2014 |
Contemporary use of ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia: CAPTURE study experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Cohort Studies; Community-Acquired Infections; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Staphylococcus aureus; Streptococcus pneumoniae; Young Adult | 2014 |
[Clinical characteristics and antimicrobial resistance of invasive group A β-hemolytic streptococcus infection in children].
Topics: Abscess; Adolescent; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Clindamycin; Community-Acquired Infections; Drug Resistance, Bacterial; Female; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Retrospective Studies; Soft Tissue Infections; Streptococcal Infections; Streptococcus pyogenes | 2014 |
[Ceftaroline fosamil in community-acquired and nosocomial pneumonia].
Topics: Animals; Ceftaroline; Cephalosporins; Clinical Trials as Topic; Community-Acquired Infections; Cross Infection; Humans; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Pneumonia, Staphylococcal; Streptococcus pneumoniae | 2014 |
Clinical manifestations and prognostic factors of Morganella morganii bacteremia.
Topics: Age Factors; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Morganella morganii; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Risk Factors; Taiwan | 2015 |
Susceptibility of Escherichia coli from community-acquired urinary tract infection to fosfomycin, nitrofurantoin, and temocillin in Korea.
Topics: Anti-Bacterial Agents; Cefepime; Cell Survival; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Nitrofurantoin; Penicillins; Republic of Korea; Sulfadoxine; Treatment Outcome; Trimethoprim; Urinary Tract Infections | 2014 |
Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in elderly patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Drug Utilization; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Retrospective Studies; Skin Diseases, Bacterial | 2014 |
Community-acquired pneumonia: impact of empirical antibiotic therapy without respiratory fluoroquinolones nor third-generation cephalosporins.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Basidiomycota; Cephalosporins; Cohort Studies; Community-Acquired Infections; Critical Care; Drug Therapy, Combination; Female; Fluoroquinolones; Guidelines as Topic; Humans; Length of Stay; Male; Middle Aged; Pneumonia, Bacterial; Severity of Illness Index; Survival Analysis; Treatment Outcome | 2015 |
[Antimicrobial properties of ceftaroline fosamil].
Topics: Ceftaroline; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Cross Infection; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests | 2014 |
[Zinforo™ (ceftaroline fosamil)--A new beta-lactam-cephalosporin with MRSA activity].
Topics: Ceftaroline; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Staphylococcal Infections | 2014 |
Ceftaroline fosamil for treating skin and skin structure infections or community-acquired pneumonia in patients with renal insufficiency.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Female; Humans; Male; Middle Aged; Pneumonia; Renal Insufficiency; Retrospective Studies; Skin Diseases, Bacterial; Young Adult | 2015 |
Time to reconsider how we do antibiotic therapy trials.
Topics: Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Female; Humans; Male; Pneumonia | 2015 |
Flomoxef showed excellent in vitro activity against clinically important gram-positive and gram-negative pathogens causing community- and hospital-associated infections.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; China; Community-Acquired Infections; Cross Infection; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospitals, University; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sequence Analysis, DNA | 2015 |
Pharmacokinetic/pharmacodynamic analysis to evaluate ceftaroline fosamil dosing regimens for the treatment of community-acquired bacterial pneumonia and complicated skin and skin-structure infections in patients with normal and impaired renal function.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Europe; Humans; Infusions, Intravenous; Kidney; Kidney Function Tests; Monte Carlo Method; Pneumonia, Bacterial; Skin Diseases, Bacterial; Treatment Outcome | 2015 |
[Resistance surveillance of major pathogens for adult community-acquired respiratory tract infections in China: a multicenter study 2012].
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cephalosporins; China; Clarithromycin; Community-Acquired Infections; Drug Resistance, Bacterial; Haemophilus influenzae; Humans; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillins; Respiratory Tract Infections; Streptococcus pneumoniae | 2015 |
Ceftaroline fosamil as first-line versus second-line treatment for acute bacterial skin and skin structure infections (ABSSSI) or community-acquired bacterial pneumonia (CABP).
Topics: Adult; Aged; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Registries; Retrospective Studies; Skin Diseases, Bacterial | 2016 |
High variability among Emergency Departments in 3rd-generation cephalosporins and fluoroquinolones use for community-acquired pneumonia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Drug Utilization; Emergency Service, Hospital; Female; Fluoroquinolones; France; Humans; Male; Penicillins; Pneumonia, Bacterial; Prohibitins; Retrospective Studies; Treatment Outcome | 2015 |
Genotypic Characterization of Methicillin-Resistant Staphylococcus aureus Recovered at Baseline from Phase 3 Pneumonia Clinical Trials for Ceftobiprole.
Topics: Anti-Bacterial Agents; Asia; Bacterial Toxins; Cephalosporins; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Cross Infection; Europe; Exotoxins; Genotype; Humans; Leukocidins; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Multilocus Sequence Typing; North America; Pneumonia; South Africa; South America; Staphylococcal Infections | 2016 |
Ceftaroline fosamil for community-acquired pneumonia.
Topics: Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Female; Humans; Male; Pneumonia | 2015 |
Ceftaroline fosamil for community-acquired pneumonia--Authors' reply.
Topics: Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Female; Humans; Male; Pneumonia | 2015 |
Effects of national antibiotic stewardship and infection control strategies on hospital-associated and community-associated meticillin-resistant Staphylococcus aureus infections across a region of Scotland: a non-linear time-series study.
Topics: Aged; Anti-Bacterial Agents; Cephalosporins; Communicable Disease Control; Community-Acquired Infections; Cross Infection; Drug Utilization; Female; Hand Hygiene; Humans; Macrolides; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Prevalence; Retrospective Studies; Scotland; Staphylococcal Infections | 2015 |
[Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from class B hospitals in China during 2013 and 2014].
Topics: Anti-Bacterial Agents; Aza Compounds; Cefepime; Cephalosporins; China; Clarithromycin; Community-Acquired Infections; Drug Resistance, Bacterial; Fluoroquinolones; Haemophilus influenzae; Humans; Klebsiella pneumoniae; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Moraxella catarrhalis; Moxifloxacin; Penicillins; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus pneumoniae | 2016 |
Antimicrobial Activities of Ceftaroline and Comparator Agents against Bacterial Organisms Causing Bacteremia in Patients with Skin and Skin Structure Infections in U.S. Medical Centers, 2008 to 2014.
Topics: Academic Medical Centers; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Skin; Staphylococcal Skin Infections; Streptococcal Infections; Streptococcus; Tigecycline; United States | 2016 |
Antimicrobial susceptibility patterns of community- and hospital-acquired methicillin-resistant Staphylococcus aureus from United States Hospitals: results from the AWARE Ceftaroline Surveillance Program (2012-2014).
Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Community-Acquired Infections; Cross Infection; Epidemiological Monitoring; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pneumonia, Staphylococcal; Staphylococcal Infections; Staphylococcal Skin Infections; United States | 2016 |
Impact of an evidence-based guideline on the management of community-acquired bacterial meningitis: a prospective cohort study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Brain; Cephalosporins; Community-Acquired Infections; Disease Management; Evidence-Based Medicine; Humans; Interrupted Time Series Analysis; Meningitis, Bacterial; Middle Aged; Netherlands; Practice Guidelines as Topic; Prospective Studies; Spinal Puncture; Tomography, X-Ray Computed; Young Adult | 2016 |
Population PK Modeling and Target Attainment Simulations to Support Dosing of Ceftaroline Fosamil in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia.
Topics: Acute Disease; Adolescent; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Community-Acquired Infections; Computer Simulation; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Models, Biological; Pneumonia, Bacterial; Skin Diseases, Bacterial; Staphylococcus aureus; Streptococcus pneumoniae | 2017 |
Clinical and Molecular Characterization of Community-Onset Urinary Tract Infections Due to Extended-Spectrum Cephalosporin-Resistant Enterobacteriaceae.
Topics: Academic Medical Centers; Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Cephalosporin Resistance; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Emergency Service, Hospital; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gram-Negative Facultatively Anaerobic Rods; Humans; Logistic Models; Male; Middle Aged; Pennsylvania; Polymerase Chain Reaction; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2016 |
Klebsiella pneumoniae bloodstream infections at a South African children's hospital 2006-2011, a cross-sectional study.
Topics: Bacteremia; beta-Lactamases; Cephalosporins; Child, Preschool; Community-Acquired Infections; Cross Infection; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; HIV Infections; Hospitals, Pediatric; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Retrospective Studies; Risk Factors; South Africa | 2016 |
Etest® versus broth microdilution for ceftaroline MIC determination with Staphylococcus aureus: results from PREMIUM, a European multicentre study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Europe; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Staphylococcal; Staphylococcal Skin Infections; Staphylococcus aureus; Young Adult | 2017 |
Propensity score-matched analysis comparing the therapeutic efficacies of cefazolin and extended-spectrum cephalosporins as appropriate empirical therapy in adults with community-onset Escherichia coli, Klebsiella spp. and Proteus mirabilis bacteraemia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cohort Studies; Community-Acquired Infections; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Male; Middle Aged; Propensity Score; Proteus Infections; Proteus mirabilis; Retrospective Studies; Survival Analysis; Treatment Outcome | 2016 |
Clinical Benefit of Appropriate Empirical Fluoroquinolone Therapy for Adults with Community-Onset Bacteremia in Comparison with Third-Generation-Cephalosporin Therapy.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Community-Acquired Infections; Female; Fluoroquinolones; Humans; Kaplan-Meier Estimate; Male | 2017 |
Cardiac Arrest in Pediatric Patients Receiving Azithromycin.
Topics: Azithromycin; Cardiopulmonary Resuscitation; Cephalosporins; Cohort Studies; Community-Acquired Infections; Databases, Factual; Female; Heart Arrest; Hospital Mortality; Humans; Male; Multivariate Analysis; Penicillins; Pneumonia, Bacterial; Retrospective Studies; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Survival Analysis; Treatment Outcome | 2017 |
Etiologies of community-onset urinary tract infections requiring hospitalization and antimicrobial susceptibilities of causative microorganisms.
Topics: Aged; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Enterobacteriaceae; Enterococcus; Female; Hospitalization; Humans; Male; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Retrospective Studies; Staphylococcus aureus; Urinary Tract Infections | 2017 |
Activities of ceftobiprole, linezolid, vancomycin, and daptomycin against community-associated and hospital-associated methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Cross Infection; Daptomycin; Drug Synergism; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2008 |
Initial antibiotic selection and patient outcomes: observations from the National Pneumonia Project.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Female; Fluoroquinolones; Hospitalization; Humans; Macrolides; Male; Pneumonia, Bacterial; Retrospective Studies; Treatment Outcome | 2008 |
Antibacterial activity of cefditoren against major community-acquired respiratory pathogens recently isolated in Italy.
Topics: Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Haemophilus influenzae; Humans; Italy; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Streptococcus pneumoniae; Streptococcus pyogenes | 2008 |
Risk factors in community-acquired/onset urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Quinolones; Risk Factors; Urinary Tract Infections; Urologic Surgical Procedures | 2008 |
Susceptibility of Escherichia coli strains isolated from outpatient children with community-acquired urinary tract infection in southern Switzerland.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Nitrofurantoin; Outpatients; Prospective Studies; Switzerland; Urinary Tract Infections; Urine | 2008 |
Activity of the new cephalosporin ceftaroline against bacteraemia isolates from patients with community-acquired pneumonia.
Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial | 2009 |
Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model
Topics: Anti-Bacterial Agents; Cephalosporins; Colony Count, Microbial; Community-Acquired Infections; Cross Infection; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Cefditoren versus community-acquired respiratory pathogens: time-kill studies.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteria; Cephalosporins; Colony Count, Microbial; Community-Acquired Infections; Humans; Microbial Sensitivity Tests; Respiratory Tract Infections; Time Factors; Treatment Outcome | 2009 |
[Estimation of the clinical and pharmacoeconomic efficiency of treatment in patients with community-acquired pneumonia with third-generation cephalosporins].
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Drug Costs; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pneumonia, Bacterial; Treatment Outcome; Young Adult | 2009 |
[Clinical characteristics and changing epidemiology of Clostridium difficile-associated disease (CDAD)].
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacterial Toxins; Cephalosporins; Clostridioides difficile; Community-Acquired Infections; Cross Infection; Enterocolitis, Pseudomembranous; Enterotoxins; Female; Humans; Male; Metronidazole; Middle Aged; Quinolones; Retrospective Studies | 2009 |
[Treatment of community-acquired pneumonia in adults: ertapenem versus cefditoren?].
Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Ertapenem; Humans; Ofloxacin; Pneumonia, Bacterial | 2010 |
Impact of an intervention to control Clostridium difficile infection on hospital- and community-onset disease; an interrupted time series analysis.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Clostridioides difficile; Clostridium Infections; Community-Acquired Infections; Cross Infection; Doxycycline; Drug Utilization; Health Services Research; Hospitals; Humans; Infection Control; Organizational Policy; Prevalence; Quinolones | 2010 |
[Management of community acquired pneumonia in adults following clinical guidelines at a rural hospital].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Chile; Community-Acquired Infections; Drug Administration Schedule; Female; Guideline Adherence; Hospitals, Rural; Humans; Immunocompetence; Length of Stay; Male; Middle Aged; Pneumonia; Treatment Outcome; Young Adult | 2009 |
Community-acquired upper respiratory tract infections and the role of third-generation oral cephalosporins.
Topics: Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Pneumococcal Infections; Pneumococcal Vaccines; Respiratory Tract Infections | 2010 |
In vitro bactericidal activity of ceftobiprole against hospital- and community-associated methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Cephalosporins; Colony Count, Microbial; Community-Acquired Infections; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Staphylococcal Infections | 2010 |
[Evaluation of clinical practice, medical computerized database and improvement of antibiotic therapy for acute community-acquired pneumonia].
Topics: Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Consensus; Databases as Topic; Fluoroquinolones; France; Hospitalization; Humans; Length of Stay; Pneumonia; Treatment Failure; Treatment Outcome | 2010 |
Changing etiology of community-acquired bacterial meningitis in adults: a nationwide multicenter study in Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Cephalosporins; Cognition Disorders; Community-Acquired Infections; Female; Humans; Male; Meningitis, Bacterial; Middle Aged; Penicillin Resistance; Prevalence; Republic of Korea; Retrospective Studies; Vancomycin; Young Adult | 2010 |
Comparative in vitro activity of cefditoren and other antimicrobials against Enterobacteriaceae causing community-acquired uncomplicated urinary tract infections in women: a Spanish nationwide multicenter study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Automation; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Infant; Microbial Sensitivity Tests; Middle Aged; Spain; Urinary Tract Infections; Young Adult | 2010 |
Antibiotic susceptibility of respiratory pathogens recently isolated in Italy: focus on cefditoren.
Topics: Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Italy; Microbial Sensitivity Tests; Respiratory Tract Infections | 2010 |
In vitro antimicrobial activity of cefditoren and other oral antibiotics against Streptococcus pneumoniae, isolated from children with community acquired respiratory tract infections.
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefuroxime; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Korea; Respiratory Tract Infections; Streptococcus pneumoniae | 2010 |
Ceftaroline fosamil: drug profile and clinical data.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Ceftaroline; Cephalosporins; Clinical Trials as Topic; Community-Acquired Infections; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mice; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rabbits; Skin Diseases, Bacterial | 2011 |
[Evolution of Escherichia coli resistance in community acquired peritonitis].
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Appendicitis; beta-Lactams; Cephalosporins; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Intestines; Male; Morocco; Peptic Ulcer Perforation; Peritonitis; Practice Guidelines as Topic; Prospective Studies | 2011 |
Ceftaroline fosamil (Teflaro) - a new IV cephalosporin.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Humans; Infusions, Intravenous; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Bacterial; Skin Diseases, Bacterial; Staphylococcal Infections | 2011 |
A clinical solution to antimicrobial resistance in community-acquired pneumonia: narrowing the spectrum of antimicrobial therapy: comment on "Current and potential usefulness of pneumococcal urinary antigen detection in hospitalized patients with communit
Topics: Antigens, Bacterial; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Penicillins; Pneumonia, Pneumococcal; Point-of-Care Systems; Quinolones; Streptococcus pneumoniae | 2011 |
Ceftaroline pharmacodynamic activity versus community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus, heteroresistant vancomycin-intermediate S. aureus, vancomycin-intermediate S. aureus and vancomycin-resistant S. aureus
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Cross Infection; Humans; In Vitro Techniques; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Staphylococcal Infections; Vancomycin Resistance | 2011 |
Comparative ceftaroline activity tested against pathogens associated with community-acquired pneumonia: results from an international surveillance study.
Topics: Anti-Bacterial Agents; Bacteria; Ceftaroline; Cephalosporins; Community-Acquired Infections; Europe; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial; United States | 2011 |
Occurrence & antibiogram of Salmonella Typhi & S. Paratyphi A isolated from Rourkela, Orissa.
Topics: Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Multiple; Fever; Humans; Incidence; India; Microbial Sensitivity Tests; Paratyphoid Fever; Salmonella paratyphi A; Salmonella typhi; Sanitation; Typhoid Fever; Water Pollutants | 2011 |
Changing needs of community-acquired bacterial pneumonia: experience with ceftaroline fosamil. Preface.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Humans; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Treatment Outcome | 2011 |
MRSA guidelines: a matter of time.
Topics: Ceftaroline; Cephalosporins; Community-Acquired Infections; Guidelines as Topic; Humans; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pneumonia; Staphylococcal Infections | 2011 |
Prescription of antibiotics for adults hospitalized with community-acquired pneumonia in Korea in 2004: a population-based descriptive study.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporins; Clindamycin; Community-Acquired Infections; Drug Prescriptions; Drug Therapy, Combination; Female; Fluoroquinolones; Guideline Adherence; Hospitalization; Humans; International Classification of Diseases; Length of Stay; Male; Middle Aged; Pneumonia, Bacterial; Practice Guidelines as Topic; Republic of Korea | 2012 |
Trends in yearly prevalence of third-generation cephalosporin and fluoroquinolone resistant Enterobacteriaceae infections and antimicrobial use in Spanish hospitals, Spain, 1999 to 2010.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cephalosporin Resistance; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Databases, Factual; Drug Resistance, Multiple, Bacterial; Drug Utilization; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Hospitals; Humans; Infant; Male; Middle Aged; Morbidity; Prevalence; Spain; Young Adult | 2011 |
Ceftaroline (Teflaro): a new cephalosporin.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Humans; Methicillin Resistance; Pneumonia, Bacterial; Skin Diseases, Bacterial; Staphylococcal Infections | 2011 |
Evaluation of ceftaroline activity versus ceftriaxone against clinical isolates of Streptococcus pneumoniae with various susceptibilities to cephalosporins in an in vitro pharmacokinetic/pharmacodynamic model.
Topics: Anti-Bacterial Agents; Ceftaroline; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Community-Acquired Infections; Culture Media; Half-Life; Humans; Microbial Sensitivity Tests; Models, Biological; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 2012 |
Activity of ceftaroline against serotyped Streptococcus pneumoniae isolates from Europe and South Africa associated with community-acquired bacterial pneumonia (2007-08).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Europe; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Pneumococcal; Serotyping; South Africa; Streptococcus pneumoniae; Young Adult | 2012 |
Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Community-Acquired Infections; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Hospitals; Humans; Male; Middle Aged; Multivariate Analysis; New Zealand; Retrospective Studies; Risk Factors | 2012 |
Proportion of extended-spectrum ß-lactamase-producing Enterobacteriaceae in community setting in Ngaoundere, Cameroon.
Topics: Adult; beta-Lactam Resistance; beta-Lactamases; Cameroon; Carrier State; Cephalosporins; Community-Acquired Infections; Drug Utilization; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Female; Human Experimentation; Humans; Male; Microbial Sensitivity Tests; Outpatients; Polymerase Chain Reaction; Risk Factors; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2012 |
In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
Topics: Anti-Bacterial Agents; Cephalosporins; China; Community-Acquired Infections; Drug Resistance, Bacterial; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Streptococcus pneumoniae | 2012 |
[Emergence of resistance to third generation cephalosporins by Enterobacteriaceae causing community-onset urinary tract infections in hospitals in Colombia].
Topics: Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactamases; Case-Control Studies; Cephalosporin Resistance; Cephalosporins; Colombia; Community-Acquired Infections; Escherichia coli; Female; Hospitals; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Proteus mirabilis; Risk Factors; Urinary Tract Infections | 2013 |
Genotypes and cephalosporin susceptibility in extended-spectrum beta-lactamase producing enterobacteriaceae in the community.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Cross-Sectional Studies; Escherichia coli; Escherichia coli Infections; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Young Adult | 2012 |
AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Streptococcus pneumoniae; United States | 2012 |
Ceftaroline potency among 9 US Census regions: report from the 2010 AWARE Program.
Topics: Anti-Bacterial Agents; Bacteria; Ceftaroline; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; United States | 2012 |
Ceftobiprole efficacy in vitro against Panton-Valentine leukocidin production and in vivo against community-associated methicillin-resistant Staphylococcus aureus osteomyelitis in rabbits.
Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Cephalosporins; Colony Count, Microbial; Community-Acquired Infections; Exotoxins; Female; Leukocidins; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; Osteomyelitis; Rabbits; Rifampin | 2012 |
An update for community-acquired bacterial pneumonia pharmacotherapy: what's new and where does it fit?
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Drug Approval; Humans; Minocycline; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Tigecycline; United States | 2012 |
[Bacterial pneumonia in HIV-infected patients (excluding mycobacterial infection)].
Topics: Actinomycetales Infections; AIDS-Related Opportunistic Infections; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; Cephalosporins; Community-Acquired Infections; Evidence-Based Medicine; France; Haemophilus influenzae; HIV Infections; Humans; Immunocompromised Host; Influenza Vaccines; Nocardia Infections; Pneumococcal Vaccines; Pneumonia, Bacterial; Rhodococcus equi; Severity of Illness Index; Streptococcus pneumoniae; Treatment Outcome | 2012 |
[Group A streptococcal meningitis].
Topics: Amoxicillin; Ampicillin; Cephalosporins; Child, Preschool; Community-Acquired Infections; Cross Infection; Female; Hospitals, University; Humans; Incidence; Infant; Infant, Newborn; Male; Meningitis, Bacterial; Morocco; Postoperative Complications; Streptococcal Infections; Streptococcus pyogenes | 2012 |
Early response of ceftaroline fosamic in the treatment of soft-tissue infections.
Topics: Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Community-Acquired Infections; Endpoint Determination; Humans; Pneumonia; Randomized Controlled Trials as Topic; Retrospective Studies; Soft Tissue Infections; Time Factors; Treatment Outcome; Vancomycin | 2012 |
Spectrum and potency of ceftaroline tested against leading pathogens causing community-acquired respiratory tract infections in Europe (2010).
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Ceftaroline; Cephalosporins; Community-Acquired Infections; Europe; Humans; Microbial Sensitivity Tests; Respiratory Tract Infections | 2013 |
[Bacteriology of community-acquired peritonitis in children treated in the university hospital of Marrakech].
Topics: Adolescent; Anti-Bacterial Agents; Ascitic Fluid; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Escherichia coli Infections; Female; Hospitals, University; Humans; Infant; Male; Metronidazole; Microbial Sensitivity Tests; Morocco; Peritonitis | 2013 |
[beta-lactam-antibiotics in the treatment of community-acquired respiratory tract infections with penicillin-resistant pneumococci].
Topics: Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Germany; Humans; Penicillin Resistance; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae | 2002 |
Limited value of routine microbiological diagnostics in patients hospitalized for community-acquired pneumonia.
Topics: Adolescent; Age Factors; Aged; Cephalosporins; Community-Acquired Infections; Diagnostic Tests, Routine; Diarrhea; Doxycycline; Female; Hospitalization; Humans; Macrolides; Male; Penicillins; Pneumonia; Retrospective Studies; Risk Factors; Statistics as Topic; Treatment Outcome | 2002 |
Management of patients with community-acquired pneumonia treated in hospital in Sweden.
Topics: Adolescent; Aged; Cephalosporins; Cohort Studies; Community-Acquired Infections; Female; Haemophilus influenzae; Hospitalization; Humans; Male; Mycoplasma pneumoniae; Penicillins; Pneumonia; Streptococcus pneumoniae; Sweden; Treatment Outcome | 2002 |
[Therapy for children with acute pneumococcal otitis media in an outpatient clinic].
Topics: Acute Disease; Amoxicillin; Cephalosporins; Child, Preschool; Community-Acquired Infections; Humans; Infant; Middle Ear Ventilation; Otitis Media; Penicillin Resistance; Pneumococcal Infections; Recurrence; Retrospective Studies; Streptococcus pneumoniae; Treatment Outcome | 2001 |
[Epidemiological study on patients with pneumococcal respiratory tract infection in a Japanese health facility during the past year].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Chronic Disease; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Lactams; Male; Middle Aged; Ofloxacin; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae; Time Factors | 2001 |
[High-dose cefditren therapy for children with acute otitis media that had Streptococcus pneumoniae and haemophilus influenzae isolated from the nasopharynx].
Topics: Acute Disease; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Nasopharynx; Otitis Media; Penicillin Resistance; Pneumococcal Infections; Pulse Therapy, Drug; Retrospective Studies; Severity of Illness Index; Streptococcus pneumoniae; Treatment Outcome | 2001 |
[Bacteriological aspects in the mid term report of the CDTR clinical trial for PRSP and BLNAR infections].
Topics: Acute Disease; Ampicillin Resistance; beta-Lactamases; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Bacterial; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Otitis Media; Penicillin Resistance; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae | 2001 |
[Comparative study on bacterial eradication rate and clinical efficacy of CDTR, CFPN, and FRPM for treatment of children with otitis media and lower respiratory tract infection due to Streptococcus pneumoniae and Haemophilus influenzae].
Topics: Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Lactams; Otitis Media; Penicillin Resistance; Pneumococcal Infections; Respiratory Tract Infections; Retrospective Studies; Streptococcus pneumoniae; Treatment Outcome | 2001 |
[Infant case of acute otitis media due to PISP not eradicated with double-dose of CDTR].
Topics: Cephalosporins; Community-Acquired Infections; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Otitis Media with Effusion; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae; Treatment Failure; Treatment Outcome | 2001 |
[Mode of transmission and natural course of pneumococcal infection].
Topics: Age Factors; Cephalosporins; Child Day Care Centers; Community-Acquired Infections; Disease Transmission, Infectious; Humans; Infant; Nasopharynx; Penicillin Resistance; Pneumococcal Infections; Risk Factors; Streptococcus pneumoniae | 2001 |
Impact of initial antibiotic choice on clinical outcomes in community-acquired pneumonia: analysis of a hospital claims-made database.
Topics: 4-Quinolones; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Fluoroquinolones; Hospital Costs; Humans; Length of Stay; Macrolides; Middle Aged; Outcome Assessment, Health Care; Penicillins; Pneumonia | 2003 |
Contemporary evaluation of the in vitro activity and spectrum of cefdinir compared with other orally administered antimicrobials tested against common respiratory tract pathogens (2000-2002).
Topics: Administration, Oral; Anti-Bacterial Agents; Brazil; Cefdinir; Cephalosporins; Community-Acquired Infections; Drug Resistance, Multiple; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Sensitivity and Specificity; Streptococcus pneumoniae | 2003 |
[Resistance surveillance of common community respiratory pathogens isolated in China, 2002 - 2003].
Topics: Anti-Bacterial Agents; Cefprozil; Cephalosporins; Child, Preschool; China; Community-Acquired Infections; Drug Resistance, Bacterial; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Moraxella catarrhalis; Multicenter Studies as Topic; Ofloxacin; Penicillins; Respiratory Tract Infections; Streptococcus pneumoniae | 2004 |
Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Asia; Cephalosporin Resistance; Cephalosporins; Community-Acquired Infections; Female; Humans; Macrolides; Male; Microbial Sensitivity Tests; Middle Aged; Penicillin Resistance; Penicillins; Pneumonia, Pneumococcal; Population Surveillance; Prospective Studies; Streptococcus pneumoniae; Treatment Outcome | 2004 |
Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor.
Topics: Amoxicillin; Cephalosporins; Community-Acquired Infections; Female; Humans; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia; Prognosis; Prospective Studies; Risk Factors; Streptococcus pneumoniae | 2004 |
Cefdinir activity against contemporary North American isolates from community-acquired urinary tract infections.
Topics: Anti-Infective Agents; Cefdinir; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Escherichia coli; Humans; Klebsiella; Microbial Sensitivity Tests; North America; Staphylococcus; Urinary Tract Infections | 2005 |
[Comparison of pharmacokinetics/pharmacodynamics of cefdinir, cefpodoxime proxetil and cefaclor against common bacteria of community acquired infections].
Topics: Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Community-Acquired Infections; Humans; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus pneumoniae | 2004 |
[Microbiological diagnostic and antibiotic management of community aquired and nosocomial pneumonias in intensive care units in Germany].
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Bronchoalveolar Lavage Fluid; Cephalosporins; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Enzyme Inhibitors; Germany; Guidelines as Topic; Humans; Intensive Care Units; Penicillins; Piperacillin; Pneumonia; Population Surveillance; Respiration, Artificial; Surveys and Questionnaires | 2005 |
Gram-negative bacterial resistance to cephalosporins in community-acquired infections in Turkey.
Topics: Anti-Bacterial Agents; Cephalosporin Resistance; Cephalosporins; Community-Acquired Infections; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Turkey | 2005 |
Pseudomonas aeruginosa infective endocarditis presenting as bacterial meningitis.
Topics: Acyclovir; Ampicillin; Calcification, Physiologic; Cefepime; Cephalosporins; Community-Acquired Infections; Diagnosis, Differential; Echocardiography, Transesophageal; Endocarditis, Bacterial; Female; Gentamicins; Humans; Meningitis, Bacterial; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Vancomycin | 2005 |
[Results of the study on antibiotic resistance emergence among pathogens of community-acquired urinary tract infections in Moscow. Phase I].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; Bacterial Infections; Cephalosporins; Community-Acquired Infections; Drug Resistance; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Male; Middle Aged; Moscow; Ofloxacin; Urinary Tract Infections | 2005 |
Detection of a novel variant bla(CTX-M-3) extended spectrum beta-lactamase gene in a community-acquired Escherichia coli isolate.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Child, Preschool; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Female; Genetic Variation; Greece; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Urinary Tract Infections | 2006 |
Antibiotic treatment of community acquired pneumonia varies widely across Germany.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Germany; Humans; Macrolides; Male; Middle Aged; Multivariate Analysis; Pneumonia, Bacterial; Practice Patterns, Physicians'; Treatment Outcome | 2007 |
Community-acquired versus nosocomial Klebsiella pneumoniae bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; APACHE; Bacteremia; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome | 2006 |
Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cephalosporins; Cohort Studies; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2006 |
Penicillin resistance not a factor in outcome from invasive Streptococcus pneumoniae community-acquired pneumonia in adults when appropriate empiric therapy is started.
Topics: Aged; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Humans; Macrolides; Microbial Sensitivity Tests; Middle Aged; Odds Ratio; Penicillin Resistance; Penicillins; Pneumonia, Pneumococcal; Retrospective Studies; Streptococcus pneumoniae; Treatment Outcome; West Virginia | 2007 |
Community-acquired versus nosocomial Klebsiella pneumonia bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance.
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Treatment Outcome | 2007 |
Activity of ceftobiprole against community-associated methicillin-resistant Staphylococcus aureus isolates recently recovered from US military trainees.
Topics: Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Military Personnel; Staphylococcal Infections; Staphylococcus aureus; United States | 2007 |
Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactam Resistance; beta-Lactamases; Carrier State; Case-Control Studies; Cephalosporins; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Prevalence; Risk Factors; Thailand | 2007 |
Meningococcal meningitis is still the commonest neuroinfection in the community in tropics: overview of 62 cases.
Topics: Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Humans; Meningitis, Meningococcal; Meningococcal Infections; Outcome Assessment, Health Care; Penicillins; Retrospective Studies; Risk Factors; Tropical Medicine | 2007 |
Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ceftaroline; Cephalosporins; Community-Acquired Infections; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; United States | 2008 |
A comparative study of bacteremic and non-bacteremic pneumococcal pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antigens, Bacterial; Bacteremia; Cephalosporins; Community-Acquired Infections; Female; Fluoroquinolones; Humans; Length of Stay; Macrolides; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Pneumococcal; Retrospective Studies; Streptococcus pneumoniae; Treatment Outcome | 2008 |
Antimicrobial activity of cefditoren tested against contemporary (2004-2006) isolates of Haemophilus influenzae and Moraxella catarrhalis responsible for community-acquired respiratory tract infections in the United States.
Topics: Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; United States | 2008 |
Pharmacodynamic characterization of ceftobiprole in experimental pneumonia caused by phenotypically diverse Staphylococcus aureus strains.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Cross Infection; Disease Models, Animal; Drug Resistance, Bacterial; Female; Humans; Methicillin Resistance; Mice; Mice, Inbred BALB C; Phenotype; Pneumonia, Staphylococcal; Staphylococcus aureus | 2008 |
Update of the activity of cefditoren and comparator oral beta-lactam agents tested against community-acquired Streptococcus pneumoniae isolates (USA, 2004-2006).
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Respiratory Tract Infections; Streptococcus pneumoniae | 2008 |
Drug-resistant Streptococcus pneumoniae.
Topics: beta-Lactam Resistance; Ceftazidime; Cephalosporins; Community-Acquired Infections; Pneumococcal Infections; Pneumonia, Bacterial; Streptococcus pneumoniae | 1996 |
Clinical characteristics and outcome of Acinetobacter infections in CAPD patients.
Topics: Acinetobacter; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Cross Infection; Humans; Microbial Sensitivity Tests; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Treatment Outcome | 1994 |
Klebsiella pneumoniae meningitis: prognostic factors.
Topics: Adult; Aged; Cephalosporins; Community-Acquired Infections; Cross Infection; Female; Humans; Incidence; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Meningitis, Bacterial; Middle Aged; Prognosis; Taiwan | 1994 |
[Antimicrobial activities of cefuroxime against recent clinical isolates].
Topics: Bacteria; Cefuroxime; Cephalosporins; Community-Acquired Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Staphylococcus; Streptococcus | 1994 |
Resistance to ceftriaxone and other beta-lactams in bacteria isolated in the community. The Vigil'Roc Study Group.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactam Resistance; beta-Lactamases; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Enterobacteriaceae; Haemophilus influenzae; Hospitalization; Humans; Microbial Sensitivity Tests; Quality Control; Staphylococcus; Streptococcus pneumoniae | 1995 |
Switch therapy in community-acquired pneumonia.
Topics: Administration, Oral; Anti-Infective Agents; Cefixime; Cefotaxime; Cephalosporins; Community-Acquired Infections; Hospitalization; Humans; Infusions, Intravenous; Pneumonia; Treatment Outcome; United Kingdom | 1996 |
Comparative in-vitro activity of cefaclor against urinary tract isolates of Escherichia coli.
Topics: Ampicillin; Cefaclor; Cephalosporins; Community-Acquired Infections; Escherichia coli; Humans; Microbial Sensitivity Tests; Penicillins; Urinary Tract Infections | 1996 |
Antibiotic susceptibility patterns of community-acquired respiratory isolates of Moraxella catarrhalis in western Europe and in the USA. The Alexander Project Collaborative Group.
Topics: 4-Quinolones; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cephalosporins; Community-Acquired Infections; Drug Resistance, Microbial; Europe; Humans; Macrolides; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillin Resistance; Respiratory Tract Infections; United States | 1996 |
Prospective study of epidemiology and prognostic factors in community-acquired pneumonia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Cephalosporins; Chlamydophila pneumoniae; Community-Acquired Infections; Drug Resistance, Microbial; Erythromycin; Female; Haemophilus influenzae; Humans; Male; Middle Aged; Mycoplasma pneumoniae; Penicillin Resistance; Pneumonia, Bacterial; Prognosis; Prospective Studies; Streptococcus pneumoniae | 1996 |
[Ceftriaxone in community-acquired infections in adults].
Topics: Adult; Ceftriaxone; Cephalosporins; Community-Acquired Infections; France; Humans; Risk Factors | 1997 |
[Treatment of community-acquired infections in children].
Topics: Age Factors; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Humans; Infant | 1997 |
Health care resource utilization and antimicrobial use in elderly patients with community-acquired lower respiratory tract infection who develop Clostridium difficile-associated diarrhoea.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Cephalosporins; Clostridioides difficile; Community-Acquired Infections; Diarrhea; Female; Fever; Hospitals; Humans; Length of Stay; Male; Prospective Studies; Radiography; Respiratory Tract Infections | 1997 |
Severe community-acquired pneumonia caused by atypical organisms.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Clarithromycin; Clavulanic Acids; Community-Acquired Infections; Critical Care; Diagnosis, Differential; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; Humans; Male; Middle Aged; Netilmicin; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Psittacosis; Radiography; Treatment Failure | 1997 |
[Trends in community-acquired infections and their therapy: focused on the role of cefcapene pivoxil. A discussion].
Topics: Bacterial Infections; Cephalosporins; Child; Community-Acquired Infections; Humans; Prodrugs; Skin Diseases; Urinary Tract Infections | 1997 |
Cefuroxime compared to amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefuroxime; Cephalosporins; Clavulanic Acids; Community-Acquired Infections; Drug Therapy, Combination; Humans; Pneumonia, Bacterial | 1997 |
[The prescription of injectable cephalosporins for community-acquired infections in Italy: use or abuse?].
Topics: Administration, Oral; Cephalosporins; Community-Acquired Infections; Drug Prescriptions; Family Practice; Female; Humans; Injections; Italy; Male | 1997 |
Community-acquired Legionnaires' disease following minimal exposure to a contaminated source.
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Fluorescent Antibody Technique, Indirect; Humans; Legionella pneumophila; Legionnaires' Disease; Male; Middle Aged; Penicillins; Rifampin; Water Microbiology; Water Supply | 1997 |
The choice of antibacterial drugs.
Topics: Administration, Oral; Anti-Bacterial Agents; Cefotaxime; Ceftazidime; Cephalosporins; Community-Acquired Infections; Costs and Cost Analysis; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Humans; Macrolides; Meningitis, Bacterial; Meningitis, Meningococcal; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Neutropenia; Pneumococcal Infections; Pneumonia, Bacterial; Systemic Inflammatory Response Syndrome; Urinary Tract Infections | 1998 |
[Antimicrobial activities of cefcapene against clinical isolates from respiratory tract infections of outpatients].
Topics: Cephalosporins; Community-Acquired Infections; Drug Resistance, Microbial; Haemophilus influenzae; Humans; Moraxella catarrhalis; Outpatients; Prodrugs; Respiratory Tract Infections; Streptococcus pneumoniae | 1998 |
Antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens isolated in the UK during the 1995-1996 cold season.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; Cefaclor; Cephalosporins; Ciprofloxacin; Clarithromycin; Common Cold; Community-Acquired Infections; Dose-Response Relationship, Drug; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Multicenter Studies as Topic; Penicillins; Respiratory System; Respiratory Tract Infections; Streptococcus pneumoniae; United Kingdom | 1998 |
Community acquired pneumonia in elderly people. Current British guidelines need revision.
Topics: Aged; Cephalosporins; Community-Acquired Infections; Drug Resistance, Microbial; Hospitalization; Humans; Pneumonia, Bacterial; Practice Guidelines as Topic | 1998 |
The importance of multiple antibiotic coverage for hospitalized patients when the community acquired pneumonia is Legionnaire's disease.
Topics: Adult; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Hospitalization; Humans; Legionnaires' Disease; Male | 1998 |
Should third-generation cephalosporins be the empirical treatment of choice for severe community-acquired pneumonia in adults?
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Australia; Cephalosporins; Child; Community-Acquired Infections; Drug Utilization; Humans; Pneumonia, Bacterial; Treatment Outcome | 1998 |
In vitro evaluation of a novel orally administered cephalosporin (Cefditoren) tested against 1249 recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Community-Acquired Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillin Resistance; Penicillins; Respiratory Tract Infections; Streptococcus pneumoniae | 1998 |
[Management of community-acquired pneumopathies of adults in the city and at the hospital].
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Hospitalization; Humans; Penicillin G; Penicillin Resistance; Penicillins; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Radiography, Thoracic | 1998 |
Cost-effectiveness of ceftriaxone in the treatment of community-acquired pneumonia in adult hospital patients.
Topics: Adult; Cefotaxime; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Cost-Benefit Analysis; Humans; Pneumonia, Bacterial; Treatment Outcome | 1998 |
Cost-effectiveness of ceftriaxone in the treatment of community-acquired pneumonia in adult hospital patients.
Topics: Adult; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Cost-Benefit Analysis; Humans; Pneumonia, Bacterial; Treatment Outcome | 1998 |
Community-acquired pneumonia.
Topics: Adult; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Drug Resistance, Microbial; Humans; Pneumonia | 1998 |
Cefepime versus ceftriaxone for empiric treatment of hospitalized patients with community-acquired pneumonia.
Topics: Cefepime; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Humans; Outcome Assessment, Health Care; Pneumonia | 1999 |
Subcutaneous nodules with pseudomonas septicaemia in an immunocompetent patient.
Topics: Adult; Ceftazidime; Cephalosporins; Community-Acquired Infections; Female; Gentamicins; Humans; Immunocompetence; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Skin Diseases, Bacterial | 1999 |
Pneumonia acquired in the community through drug-resistant Streptococcus pneumoniae.
Topics: Adult; Aged; Cephalosporins; Community-Acquired Infections; Drug Resistance, Microbial; Female; Humans; Incidence; Male; Middle Aged; Penicillin Resistance; Pneumonia, Pneumococcal; Prognosis; Streptococcus pneumoniae; Treatment Outcome | 1999 |
[Antimicrobial activities of cefetamet against clinically isolated strains from community acquired respiratory tract infections. Part III].
Topics: Anti-Bacterial Agents; Ceftizoxime; Cephalosporins; Community-Acquired Infections; Drug Resistance, Microbial; Haemophilus influenzae; Humans; Penicillin Resistance; Respiratory Tract Infections; Streptococcus pneumoniae; Streptococcus pyogenes | 1999 |
[Cefotaxime in sequential therapy of community acquired pneumonia].
Topics: Adult; Bacterial Infections; Cefotaxime; Cephalosporins; Community-Acquired Infections; Humans; Pneumonia, Bacterial | 1999 |
Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefotaxime; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Microbial; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Penicillin Resistance; Pneumonia, Pneumococcal; United States | 2000 |
Methicillin-resistant Staphylococcus aureus infections in 2 pediatric outpatients.
Topics: Ambulatory Care; Anti-Bacterial Agents; Cefazolin; Cephalexin; Cephalosporins; Child; Clindamycin; Community-Acquired Infections; Drainage; Female; Hospitalization; Humans; Infant; Methicillin Resistance; Neck; Staphylococcal Infections; Staphylococcus aureus; Toes; Treatment Failure; Vancomycin | 2000 |
Current opinion in the treatment of community-acquired pneumonia: results of the presymposium interactive question and answer session.
Topics: Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Female; Humans; Middle Aged; Pneumonia; Practice Guidelines as Topic | 2000 |
Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia.
Topics: Adolescent; Adult; Aeromonas; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Community-Acquired Infections; Cross Infection; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Lactams; Male; Middle Aged; Prognosis; Risk Factors | 2000 |
Is azithromycin monotherapy as efficacious as cefuroxime plus erythromycin for the treatment of community-acquired pneumonia in hospitalized patients?
Topics: Administration, Oral; Anti-Bacterial Agents; Azithromycin; Cefuroxime; Cephalosporins; Community-Acquired Infections; Drug Administration Schedule; Drug Therapy, Combination; Erythromycin; Hospitalization; Humans; Injections, Intravenous; Multicenter Studies as Topic; Pneumonia; Randomized Controlled Trials as Topic | 2000 |
Comparative in vitro activity of telithromycin (HMR 3647), three macrolides, amoxycillin, cefdinir and levofloxacin against gram-positive clinical isolates in Japan.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Community-Acquired Infections; Drug Resistance, Microbial; Erythromycin; Gram-Positive Bacteria; Humans; Japan; Ketolides; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Respiratory Tract Infections; Staphylococcus aureus | 2000 |
Anaerobic infection therapy.
Topics: Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Cephalosporins; Community-Acquired Infections; Drug Resistance, Microbial; Drug Therapy, Combination; Humans | 2000 |
Choice of antibiotic and risk of colonization with vancomycin-resistant Enterococcus among patients admitted for treatment of community-acquired pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Enterococcus; Erythromycin; Female; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Risk Factors; Vancomycin Resistance | 2000 |
[Microbiological evaluation of antibiotics for empirical therapy of community-acquired infections of the lower respiratory tract].
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Bronchitis; Cefuroxime; Cephalosporins; Chronic Disease; Community-Acquired Infections; Drug Resistance, Microbial; Haemophilus influenzae; Humans; Inpatients; Penicillins; Pneumonia, Bacterial; Respiratory Tract Infections; Streptococcus pneumoniae | 2000 |
Antibiotics for community-acquired pneumonia: time to return to the straight and narrow?
Topics: Adult; Australia; beta-Lactam Resistance; Cephalosporins; Community-Acquired Infections; Cross Infection; Humans; Penicillins; Pneumonia | 2001 |
The efficacy of an antibiotic protocol for community-acquired pneumonia.
Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Clinical Protocols; Community-Acquired Infections; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Erythromycin; Female; Hospital Mortality; Humans; Injections, Intravenous; Male; Middle Aged; New South Wales; Penicillin G; Penicillins; Pneumonia; Prognosis; Retrospective Studies; Statistics, Nonparametric; Treatment Outcome | 2001 |
[Cefotaxime, twenty years later. Observational study in critically ill patients].
Topics: Antibiotic Prophylaxis; Cefotaxime; Cephalosporins; Community-Acquired Infections; Critical Illness; Cross Infection; Drug Utilization; Humans; Intensive Care Units; Prospective Studies; Spain | 2001 |
Efficacy of cefepime versus ceftazidime in the treatment of adult pneumonia.
Topics: Adult; Aged; Cefepime; Ceftazidime; Cephalosporins; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial | 2001 |
Clinical analysis of community-acquired pneumonia in the elderly.
Topics: Aged; Aged, 80 and over; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Male; Pneumonia, Bacterial; Pneumonia, Viral; Prognosis; Prospective Studies | 2001 |
Effect of step-down therapy of ceftriaxone plus loracarbef versus parenteral therapy of ceftriaxone on the intestinal microflora in patients with community-acquired pneumonia.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Feces; Female; Hospitalization; Humans; Infusions, Intravenous; Intestines; Male; Middle Aged; Pneumonia; Treatment Outcome | 2001 |
E test for studying in vitro activity of seven antimicrobial agents against penicillin-susceptible and penicillin-resistant pneumococci.
Topics: Amoxicillin; Cefaclor; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Penicillin Resistance; Penicillins; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae | 2000 |
[Activity of different antimicrobial agents against penicillin-resistant Streptococcus pneumoniae].
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cefixime; Cefpodoxime; Ceftibuten; Ceftizoxime; Cefuroxime; Cephalosporins; Clavulanic Acid; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Pneumonia, Pneumococcal; Spain; Streptococcus pneumoniae | 2001 |